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Abstract 
 
New neurons are continuously added in the adult mammalian brain, in two main 
neurogenic regions: the subventricular zone, in the walls of the lateral ventricles, and 
the subgranular zone, in the dentate gyrus of the hippocampus. Neural stem cells 
present in these niches are able to proliferate and originate migrating neuroblasts, 
which ultimately differentiate into new neurons. Interestingly, in the event of a brain 
lesion, neural stem cell proliferation increases, possibly in an attempt to repair the 
damage. However, this repair is limited by impaired cell migration or decreased survival 
of new neurons. Discovering how to increase the efficiency of post-injury neurogenesis 
may therefore be beneficial for brain repair. On the other hand, brain damage can also 
activate several proteases, including calpains. Calpains are ubiquitous proteases 
known to be involved in cell proliferation, migration and differentiation in several 
systems. In the brain, calpain inhibition has been shown to be neuroprotective, but their 
effects on neurogenesis remain elusive. Deletion of the endogenous inhibitor of 
calpains, calpastatin, has previously been shown to impair early stages of 
neurogenesis in vivo. In the present work, we show that calpain inhibition is able to 
reverse this impairment, further implicating them in the process. Since calpain inhibition 
offers a promising target for the enhancement of post-injury neurogenesis, we 
evaluated different stages of the process and cognitive behavior recovery after seizure-
induced hippocampal lesion in mice overexpressing calpastatin, and also the effects of 
the absence of conventional calpains on the early stages of hippocampal 
neurogenesis. We observed that the pattern of enhancement of post-injury 
neurogenesis was mostly maintained in mice overexpressing calpastatin, though some 
cognitive recovery indicates some degree of neuroprotection, which by itself may have 
masked the influence of calpain inhibition on neurogenesis. Mice lacking calpains, 
however, presented unaltered levels of the early stages of hippocampal neurogenesis, 
suggesting that calpains only affect this process when their activity is over a certain 
threshold, under which neurogenesis is not affected. This means that calpain inhibition 
could potentially be useful to stimulate the formation of new neurons after injury, given 
that the levels of calpain activity could be reduced under a certain threshold. 
 
Keywords: Adult neurogenesis, brain injury, calpains, hippocampus, memory.  
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Resumo 
 
No cérebro adulto dos mamíferos, novos neurónios são continuamente adicionados 
em duas regiões neurogénicas principais: a zona subventricular, nas paredes dos 
ventrículos laterais, e a zona subgranular, no giro dentado do hipocampo. As células 
estaminais neurais presentes nestes nichos têm a capacidade de proliferar e dar 
origem a neuroblastos em migração, que acabam por se diferenciar em novos 
neurónios. Curiosamente, no evento de uma lesão cerebral, a proliferação das células 
estaminais neurais aumenta, possivelmente numa tentativa de reparação do dano 
cerebral. No entanto, esta reparação é limitada pela redução da migração celular ou 
pela diminuição da sobrevivência dos novos neurónios. Descobrir como aumentar a 
eficiência da neurogénese após lesão poderá ser portanto benéfico para a reparação 
cerebral. Por outro lado, o dano cerebral também pode activar diversas protéases, 
incluindo as calpaínas. As calpaínas são proteases ubíquas, sabendo-se que estão 
envolvidas na proliferação, migração e diferenciação celular em diversos sistemas. No 
cérebro, a inibição das calpaínas tem efeito neuroprotector, mas os seus efeitos na 
neurogénese permanecem ainda pouco conhecidos. A delecção do inibidor endógeno 
das calpaínas, a calpastatina, já anteriormente mostrou ser capaz de reduzir as 
primeiras fases da neurogénese in vivo. No presente trabalho, mostramos que a 
inibição das calpaínas é capaz de reverter este efeito, implicando-as ainda mais no 
processo. Uma vez que a inibição das calpaínas parece ser um alvo promissor para o 
aumento da neurogénese após lesão, avaliámos várias fases do processo 
neurogénico, bem como a recuperação das alterações do comportamento cognitivo 
após lesão no hipocampo induzida por crises epilépticas, em murganhos com 
sobrexpressão de calpastatina. Avaliámos ainda os efeitos da delecção das calpaínas 
1 e 2 nas primeiras fases da neurogénese no hipocampo. Observámos que o padrão 
de aumento da neurogénese após lesão foi mantido em murganhos com 
sobrexpressão de calpastatina, apesar de alguma recuperação cognitiva indicar algum 
grau de neuroprotecção, que por si só poderá ter mascarado a influência da inibição 
das calpaínas na neurogénese. Murganhos com falta de calpaínas, no entanto, não 
apresentaram alterações das primeiras fases da neurogénese no hipocampo, 
sugerindo que as calpaínas apenas afectam este processo quando a sua actividade 
está acima de um certo limite, abaixo do qual a neurogénese não é afectada. Isto 
significa que a inibição das calpaínas poderá potencialmente ser útil para prevenir a 
redução da formação de novos neurónios após lesão, caso os níveis de actividade das 
calpaínas possam ser reduzidos abaixo de um certo limite. 
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Abbreviations 
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Capn2 cKO (Calpain 2 conditional knockout mice) 
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Cast Ht (Calpastatin heterozygous mice) 
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CNS (Central nervous system) 
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DCX (Doublecortin) 
DG (Dentate gyrus) 
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1.1. Neurogenesis in the adult mammalian brain 
 
The brain is the most complex organ in our body. Everything we perceive of the world, 
every feeling, emotion, behavior, from every movement we make to everything we 
learn, all is processed through the brain. However, it was not until 1965, with the 
discovery of mitotic cells in the adult rat brain (Altman & Das 1965), that this organ 
started to be regarded as potentially plastic in terms of introduction of new neurons 
during adulthood, and not as immutable as previously thought. The existence of new 
neurons being formed in the adult brain has shed new light for the possibility of brain 
repair, boosting investigation in the field. 50 years later, aided by technological 
advances, the progress so far has been remarkable, allowing for a better 
understanding of the characterization, regulation and functionality of these cells, as well 
as their implications for therapeutic applications. However, given the complexity of the 
brain, there is always something more to be discovered, and thus something else that 
can be improved, in order to help increasing the efficiency of brain recovery. 
 
1.1.1. Neurogenic regions in the adult brain 
 
Neural stem cells (NSCs) are self-renewing, multipotent cells that can give origin to 
new neurons in the adult brain, in a process designated by neurogenesis. 
Neurogenesis occurs mainly in two regions: the subventricular zone (SVZ), in the wall 
of the lateral ventricles, and the dentate gyrus (DG) of the hippocampus (reviewed 
in(Bond et al. 2015) (Fig. 1.1A). There are also reports of neurogenesis occurring in 
other regions of the brain, such as the neocortex (Bernier et al. 2002, Gould et al. 
1999), striatum (Bedard et al. 2002, Ernst et al. 2014) and hypothalamus (Kokoeva et 
al. 2005), though to a much inferior degree. NSCs constitute a pool of relatively 
quiescent astrocyte-like cells that, when activated, can originate transient amplifying 
progenitor cells, which in turn give rise to neuroblasts, commiting to the neuronal 
lineage. During the first week of life, neuroblasts from the SVZ migrate in chains, 
through the rostral migratory stream (RMS), into the olfactory bulb (OB), where they 
start to migrate radially (Fig. 1.1B). By the end of the second week, migration is 
complete, and the immature neurons in the OB start growing apical and basal 
dendrites. After one month, the newborn interneurons complete synapse development 
and integration into the local networks, and comprehend mostly inhibitory granule cells, 
but also some periglomerular cells (Jin 2016). Neuroblasts from the DG, in turn, are 
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generated in the subgranular zone (SGZ), a monolayer of cells between the granular 
zone (GZ) and the hilus, in the hippocampus. These neuroblasts migrate shorter 
distances, into the GZ, and start to extend limited cellular processes during the first 
week after birth. During the following week, they start to extend apical dendrites 
through the GZ and axons to the CA3 region of the hippocampus (Jin 2016). In the 
third week, the immature neurons finally start to connect with the local neuronal 
network, but only complete maturation after 8 weeks, becoming new granule cells in 
the DG (Aimone et al. 2014) (Fig. 1.1B, amplified panel). Overall, neurogenesis can 
thus be divided into 3 main stages: NSC proliferation, neuroblast migration and 
neuronal differentiation and integration. However, survival of the newborn cells is very 
limited, with the majority of SVZ-derived cells being eliminated after reaching the OB 
and, in the DG, before leaving the SGZ (Biebl et al. 2000). 
Of interest, neurogenesis can also be observed in humans. The first clear evidence of 
newborn neurons in the adult human brain was observed in post-mortem samples of 
the hippocampus of cancer patients that had been administered a thymidine analogue 
for diagnostic purposes (Eriksson et al. 1998). The evaluation of the presence of mitotic 
cells requires incorporation of a distinct tag into the DNA of these cells which can later 
be analysed. The work of Eriksson et al. was possible because the patients had been 
administered a thymidine analogue for other purposes (cancer followup). However, 
administration of anything that can be integrated in the DNA can be mutagenic and the 
samples would only become available after the subject had died, which difficult these 
kind of studies in humans. Other approaches were therefore necessary for further 
studies on adult human neurogenesis. The fact that NSCs originate neuroblasts, which 
can be detected by the presence of doublecortin, led to the discovery that humans 
present a migratory extent of the lateral ventricles, similarly to the RMS (Curtis et al. 
2007). Despite this curious finding, doublecortin-labeling does not directly indicate the 
presence of newborn neurons. More notable advances have only started to take place 
after the development of a distinctive method for neuronal birth dating developed by the 
group of Jonas Frisén (Spalding et al. 2005). This method takes advantage of the 
extreme increase in 14C levels in the atmosphere during the above-ground nuclear 
bomb testing between 1955 and 1963, their steady decrease after that period and, 
more importantly, the fact that the DNA of dividing cells incorporates 14C in levels 
similar to the ones present in the atmosphere at the time of division, being stable in 
non-dividing cells. So far, three major findings already derived from the use of the 14C 
methodology. First, there is no significant neuronal turnover in the human OB 
(Bergmann et al. 2012), unlike what is seen in other mammals, where newborn cells 
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derived from the SVZ end up becoming new interneurons in the OB. However, the 
apparent existence of a RMS in humans led to further investigation on the destination 
of these newborn cells. Curiously, newborn neurons are present in the human striatum, 
suggesting that, in humans, SVZ-derived cells end up in the striatum, instead of the OB 
(Ernst et al. 2014). Additionally, the human hippocampus was found to harbor 
substantial neurogenesis, with a relative increase in neuronal turnover compared to 
other regions (Spalding et al. 2013). Thus, neurogenic regions are also present in the 
adult human brain, and even though SVZ-derived newborn cells are not directed to the 
OB, it may still prove itself useful for possible applications on neuronal replacement 
after brain injury. 
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Figure 1.1 - Neurogenic niches in the adult mammalian brain. (A) Coronal sections 
highlighting in orange the dentate gyrus (left) and the subventricular zone (right). (B) 
Sagittal illustration showing the migrating route (rostral migratory stream, RMS) of 
neural stem cells from the subventricular zone onto the olfactory bulb (OB), where they 
migrate radially and differentiate. Amplified panel shows a representation of 
neurogenesis in the hippocampus, with self-proliferating neural stem cells originating 
neuroblasts, which then become immature neurons in the granular zone of the dentate 
gyrus (DG), where they become fully mature neurons. LV, lateral ventricle.  
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1.1.2. Functional significance of adult neurogenesis 
 
Adult neurogenesis from the SVZ and the DG has been consistently implicated with 
learning and memory. Newborn neurons from both regions have a period of higher 
hyperexcitability and enhanced synaptic plasticity, which may contribute for distinct 
functions in the integrated circuits (Bond et al. 2015, Ge et al. 2008). Investigation of 
the roles of SVZ neurogenesis under physiological conditions has been relatively less 
extensive than in the hippocampus. Nonetheless, given that newborn cells from the 
SVZ end up mostly differentiating in the OB, their association with olfaction is not 
surprising. More specifically, newborn neurons in the OB have been shown to 
contribute to the maintenance of existing circuits and to odor learning and memory 
(Lazarini & Lledo 2011). Additionally to the generation of interneurons in the OB, NSCs 
from the SVZ can also originate a small portion of oligodendrocytes, which integrate 
the corpus callosum to myelinate axons (Xing et al. 2014). The fact that the OB in 
humans is significantly less developed, since humans do not need to rely on olfaction 
as much as other mammals, may justify the lack of newborn cells in that region. The 
significance of newborn neurons in the striatum instead still remains somewhat elusive, 
though this region can also have an involvement in cognitive functions, particularly 
when challenges in the environment require behavioral adaptation (Cools et al. 2006). 
Moreover, since the striatum is mainly related with motor control, there is a possibility 
that newborn cells in this region may be involved in learning of new motor skills. 
Adult hippocampal neurogenesis has been more extensively studied than OB 
neurogenesis in the rodent brain, possible because it simulates better what happens in 
humans. The involvement of hippocampal neurogenesis on cognition can be assessed 
by modulating neurogenesis and performing cognitive behavioral tests that evaluate 
specific kinds of memory. Several methods have been used to impair neurogenesis, 
including the use of antimitotic drugs (Shors et al. 2001), irradiation (Madsen et al. 
2003), viruses (Zhang et al. 2008, Jessberger et al. 2009) or transgenic animals 
(Dupret et al. 2008, Saxe et al. 2006, Imayoshi et al. 2008, Garcia et al. 2004). 
Experimental data from these studies was sometimes inconsistent, which may be 
explained by different responses between species or strains, efficiency and specificity 
of the methods used to impair neurogenesis, as well as differences in the performance 
of a specific test or the parameters evaluated (Deng et al. 2010). Nevertheless, the fact 
that several studies where adult hippocampal neurogenesis has been impaired reveal 
alterations in learning and memory indicate that DG neurogenesis is important for the 
maintenance of these processes (Deng et al. 2010). Interestingly, the hippocampus is 
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involved in the processes of pattern separation, the ability to discriminate between two 
similar episodes, and pattern completion, which consists of the reconstruction of a 
previous memory based only in partial elements of an episode. Since young granule 
cells seem to mediate pattern separation and old granule cells pattern completion 
(Nakashiba et al. 2012), neurogenesis can affect these processes, by altering the 
balance in the proportions of these cells. More specifically, increased neurogenesis 
may enhance pattern separation, increasing discrimination, and, conversely, impaired 
neurogenesis may enhance pattern completion, increasing generalization (Sahay et al. 
2011). If the imbalance is too pronounced, it may lead to disorders such as autism or 
anxiety, respectively, which highlights the importance of maintaining neurogenesis 
tightly regulated. 
 
1.1.3. Regulation of adult neurogenesis 
 
Adult neurogenesis can be regulated by a plethora of factors, starting with the own 
neurogenic niches, the microenvironments where neurogenesis occurs. Both the SVZ 
and the DG usually present optimal conditions for the normal maintenance of 
neurogenesis. This is accomplished by several players in the niche, including 
astrocytes, microglia, endothelial cells and also, in the case of the SVZ, ependymal 
cells. All of these cells can secrete signaling factors that will help in maintaining a pool 
of self-renewing NSCs, as well as directing migration, fate commitment, maturation and 
survival of the newborn cells (Aimone et al. 2014, Ma et al. 2009, Ming & Song 2011). 
Curiously, before integrating the existing networks, newborn cells can already be 
sensitive to neurotransmitters, such as γ-aminobutyric acid and glutamate, the primary 
neurotransmitters in the brain (Berg et al. 2013). The close proximity of both niches 
with blood vessels and of the SVZ with the lateral ventricles may also allow for other 
factors from the blood and the cerebrospinal fluid to enter the niches and interfere with 
neurogenesis (Mirzadeh et al. 2008, Tavazoie et al. 2008, Palmer et al. 2000, Shen et 
al. 2008).  
Despite the fine-tuning of adult neurogenesis occurring in the niches, several extrinsic 
factors are known to interfere with the process. Some examples include age, stress, 
enrichment, voluntary exercise and learning. With increased incidence of 
neurodegenerative disorders in the older population, it is important to understand the 
influence that age may have on the generation of new neurons. In fact, it has been 
demonstrated that aging impairs progenitor cell proliferation, as well as neuronal 
Chapter 1 
11 
 
differentiation and survival (Bondolfi et al. 2004, Kuhn et al. 1996, Heine et al. 2004). 
Moreover, direct proof of a decline in adult hippocampal neurogenesis with age has 
been recently reported to occur in humans, although to a less extent (Spalding et al. 
2013). Furthermore, both acute and chronic stressful events can also cause 
impairment of hippocampal cell proliferation and survival (Aimone et al. 2014). Even 
though age and stress negatively regulate adult neurogenesis, some extrinsic factors 
are actually able to enhance it. That is the case with enrichment of the environment 
and voluntary exercise, such as running. Enrichment is able to enhance survival of new 
granule neurons (Kempermann et al. 1997), while exercise is able to boost cell 
proliferation and survival (Snyder et al. 2009, van Praag et al. 1999). Interestingly, both 
enrichment and exercise have been shown to improve the impairment in neurogenesis 
that occurs with age (van Praag et al. 2005, Kempermann et al. 2002). The effect of 
learning on adult neurogenesis is not as straightforward. Spatial learning of 
hippocampal-dependent tasks can either promote or hinder survival of newborn cells, 
depending on their age at the time of learning (Dobrossy et al. 2003), which is just 
another indication of how complex neuronal systems can be. 
Additionally, and perhaps the regulatory event that most impact has in a potential 
clinical setting, adult neurogenesis can be deregulated after a pathologic event. 
Alterations in neurogenesis have been reported both in neurodegenerative diseases, 
such as Huntington’s, Parkinson’s and Alzheimer’s disease, and after acute brain 
insults, such as traumatic brain injury, ischemic stroke and epileptic seizures, 
addressed in the next section. 
 
1.1.4. Post-injury neurogenesis 
 
Neurodegenerative diseases are characterized by slow and progressive neuronal 
death. In Huntington’s disease, this is caused by a genetic mutation that causes 
neuronal loss mostly in the striatum and cortex, but can also affect the hippocampus. 
Hippocampal neurogenesis in animal models of this disease is impaired (Gil et al. 
2005, Lazic et al. 2004, Simpson et al. 2011, Kandasamy et al. 2010), while reports 
both in rodents and in humans indicate an enhancement of cell proliferation in the SVZ 
(Tattersfield et al. 2004, Curtis et al. 2003). Parkinson’s disease, in turn, is 
characterized by a selective loss in dopaminergic neurons in the substantia nigra. Cell 
proliferation both in the SVZ and in the hippocampus of patients with Parkinson’s 
disease is impaired, which seems to be caused by loss of dopaminergic input 
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(Hoglinger et al. 2004). Recently, accumulation of α-synuclein in the hippocampus was 
also shown to be involved in the decreased survival of newly generated neurons in a 
mouse model of this disease (Schlachetzki et al. 2016). In Alzheimer’s disease, 
accumulation of β-amyloid peptide induces severe neuronal loss, starting in the 
hippocampus. Impairment of cell proliferation and survival of newborn neurons have 
been reported in several animal models of the disease, but alterations of these 
processes in patients with Alzheimer’s disease have not been very clear (Mu & Gage 
2011). 
Regarding acute brain lesions, the alterations observed in neurogenesis are mostly 
different. In the event of a traumatic brain injury, the hippocampus can be particularly 
affected, leading to deficits in learning and memory (Hilton 1994). Cognitive 
improvement may occur, but it is very limited and takes a considerable amount of time 
(Schmidt et al. 1999). Interestingly, however, cell proliferation in the SVZ and DG was 
shown to be increased in animal models of traumatic brain injury (Chirumamilla et al. 
2002, Dash et al. 2001, Rice et al. 2003, Gao et al. 2009). Moreover, newborn granule 
cell integration in the hippocampal network was seen to be associated with cognitive 
recovery (Emery et al. 2005, Sun et al. 2007). This enhancement of cell proliferation 
has also been observed following ischemic brain stroke, even in humans (Jin et al. 
2001, Jin et al. 2006, Macas et al. 2006, Marti-Fabregas et al. 2010, Tonchev et al. 
2003). Moreover, newborn cells are able to migrate into the damaged regions, where 
they differentiate and integrate the existing circuitry (Arvidsson et al. 2002, Nakatomi et 
al. 2002, Yamashita et al. 2006, Zhang et al. 2001). However, most of the newborn 
cells die in the process, with only around 0.2% of lost neurons ending up being 
replaced in the damaged striatum (Arvidsson et al. 2002). Furthermore, alterations of 
neurogenesis are also observed after seizures. The hippocampus is especially affected 
in temporal lobe epilepsy, the most common seizure-related disorder in humans. 
Several animal models of this condition show a significant increase in the early stages 
of neurogenesis following seizures (Carreira et al. 2015, Gray & Sundstrom 1998, 
Jiang et al. 2003, Nakagawa et al. 2000, Parent et al. 2002, Parent et al. 1997, Scott et 
al. 2000). However, some of the newborn cells seem to integrate abnormally in the 
networks, with ectopic granule cells being observed particularly in the hilus, possibly 
aggravating the outcome of the disease (Cameron et al. 2011, Dashtipour et al. 2001, 
Jessberger et al. 2007b, Scharfman et al. 2000). In patients with temporal lobe 
epilepsy, evidence of increased cell proliferation (Blumcke et al. 2001, Crespel et al. 
2005) and ectopic granule cells (Parent et al. 2006, Parent et al. 1997) have also been 
observed. Moreover, most of the newborn cells seemingly become astrocytes, reducing 
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differentiation into new neurons (Carreira et al. 2015, Hattiangady & Shetty 2010, 
Sierra et al. 2015).  
Overall, adult neurogenesis in neurodegenerative diseases appears to be negatively 
affected, while in acute disorders there seems to be an attempt to replace neurons lost 
after an insult to the brain, albeit not very efficient. If we discover how to boost or make 
the process more efficient, this endogenous potential of the brain to repair itself could 
be very useful for treatment of neurodegenerative diseases or to improve the outcome 
of acute brain disorders. Apart from the enhancement of endogenous neurogenesis, 
other strategies have also been considered for brain repair, such as transplantation of 
stem cells from different origins (Lindvall & Kokaia 2010), or even by direct conversion 
of astrocytes into neurogenic cells (Magnusson et al. 2014, Niu et al. 2013). However, 
changes in the microenvironment after injury that may affect cell survival must not be 
excluded, and understanding how they can affect neurogenesis may contribute to a 
successful outcome for brain repair. 
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1.2. Calpains 
 
Calpains are a group of intracellular Ca2+-dependent cysteine proteases, first described 
over 50 years ago in the rat brain (Guroff 1964). Since then, calpains have been 
characterized in almost all eukaryotes and some bacteria. In humans, 18 genes coding 
for calpains and calpain-related proteins have already been reported (Sorimachi et al. 
2011). Calpain isoforms are either ubiquitous or tissue-specific, and their importance is 
highlighted by the fact that their deregulation can be related to several diseases, 
including cancer, diabetes, muscular dystrophy and brain disorders (Chakraborti et al. 
2012). In this work, we will focus on the most abundant and well characterized 
ubiquitous calpain isoforms, calpain 1 and calpain 2, also known as conventional 
calpains. 
 
1.2.1. Calpain structure and modulation 
 
Calpain 1 and calpain 2 function as heterodimers, presenting a large catalytic subunit 
(80 kDa; CAPN1 and CAPN2, respectively) in association with an identical small 
regulatory subunit (CAPNS1) (Goll et al. 2003). The catalytic subunit can be divided in 
four domains (I to IV), while the regulatory subunit is divided in two (V and VI) (Fig. 
1.2).  
 
Figure 1.2 - Calpain structure. Structure of the large catalytic subunit of conventional 
calpains, CAPN1 and CAPN2 (domains I to IV), and of the small regulatory subunit 
CAPNS1 (domains V and VI). Upon activation, domains I and V can be autolyzed, 
domains IIa and IIb fold into a single functional domain, domain III is responsible for 
phospholipid binding and domains IV and VI present five CA2+-binding EF-hands each 
(in green), of which one is responsible for heterodimer formation between the large and 
the small subunits. 
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Domain I is located at the N-terminal of the catalytic subunit, and can be autolyzed in 
the presence of Ca2+, lowering the Ca2+ concentration required for calpain activation 
(Cong et al. 1989). Domain II presents two core domains (subdomains IIa and IIb), 
which fold into a single functional domain after binding with Ca2+ (Moldoveanu et al. 
2002). Ca2+ also binds to domain III, regulating phospholipid binding (Tompa et al. 
2001), and to the five EF-hands present in domain IV of the catalytic subunit and 
domains VI of the regulatory subunit (Minami et al. 1987). The fifth EF-hand motif of 
each of these domains, located in COOH-terminal, contribute to the formation of 
heterodimers (Imajoh et al. 1987). Lastly, domain V, in the N-terminal of the regulatory 
subunit, has glycine-rich clusters, which can be autolyzed upon activation (Sorimachi et 
al. 2011). 
Calpain 1 and calpain 2 require elevated levels of Ca2+ to be activated maximally in 
vitro (2-80 μM and 0.2-0.8 mM, respectively), which do not normally exist in the cell. 
Some other regulatory mechanisms for calpains have thus been proposed, which may 
help decrease the Ca2+ concentration requirement of calpains (Franco & Huttenlocher 
2005). One of them has already been mentioned, the autolysis of the domain I of the 
catalytic subunit of calpains. This truncated form of the protein has lower Ca2+ 
requirements and allows folding of domain II into a functional domain (Baki et al. 1996, 
Elce et al. 1997, Imajoh et al. 1986). Binding of phospholipids can also reduce the Ca2+ 
requirements of calpains (Melloni et al. 1996, Arthur & Crawford 1996), as well as 
several proteins identified as calpain activators (Salamino et al. 1993, Melloni et al. 
1998, Melloni et al. 2000). Moreover, phosphorylation has also been shown to 
modulate calpains, either by activating (phosphorylation by mitogen-activated protein 
kinase or protein kinase C) or inhibiting (phosphorylation by protein kinase A) them 
(Glading et al. 2000, Shiraha et al. 2002, Smith et al. 2003, Xu & Deng 2006). Lastly, 
but importantly, calpains are also regulated by their endogenous inhibitor, calpastatin 
(CAST), the only known endogenous calpain inhibitor (Murachi 1984). CAST is 
ubiquitously expressed and selective for the conventional calpains (calpain 1 and 
calpain 2), although calpain 8 and calpain 9 have been shown to be inhibited by CAST 
in vitro (Hata et al. 2007, Lee et al. 1999). CAST has four inhibitory domains, being 
thus able to bind and inhibit four calpain molecules (Emori et al. 1987, Hanna et al. 
2007). A plethora of pharmacologic inhibitors of calpains have been developed, in an 
effort to mimic CAST efficiency pharmacologically, or to selectively inhibit calpain 1 or 
calpain 2 (Donkor 2015). Although a lot of progress has been made regarding, e.g., 
stability, selectivity of calpains over other proteases and reduced toxicity, selective 
inhibition of calpain 1 or calpain 2 has been more difficult. Nonetheless, for 
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experimental studies to evaluate the roles of calpains, animal models lacking calpains 
or CAST, or overexpressing CAST, for example, can be used. To be noted, however, 
that knockout mice for calpain 2 or for the small regulatory subunit are embryonically 
lethal (Arthur et al. 2000, Dutt et al. 2006, Takano et al. 2011). In this case, conditional 
knockout animals must be used, in order to deplete the desired protein in a specific 
adult tissue, without compromising embryonic development. 
 
1.2.2. Calpain functions and dysfunctions 
 
One curious feature that distinguishes calpains from other proteolytic systems is the 
fact that products of calpain cleavage can maintain activity, indicating that they may 
modulate, rather than degrade, their substracts. Along with the fact that calpains can 
cleave over 100 substracts, including cytoskeletal and structural proteins, membrane-
bound-receptors, signaling enzymes and transcription factors, it is no wonder that they 
appear to have a role in several different biological processes (Goll et al. 2003). 
Studies that evaluate the effects of calpain inhibition have particularly brought some 
insights into the functions of calpains in several systems. However, the observed 
effects may vary, depending on the cell type examined. Decreased calpain activity has 
been associated with reduced proliferation in several cell types, including vascular 
smoothmuscle cells, Chinese hamster ovary cell colonies, osteoblasts, chondrocytes 
and lung endothelial cells (Ariyoshi et al. 1998, Kashiwagi et al. 2010, Qiu et al. 2006, 
Shimada et al. 2008, Xu & Mellgren 2002). However, impaired cell proliferation was 
also shown to occur both by calpain inhibition in mouse NSC lines (Santos et al. 2012), 
but also in hippocampal NSC, by removing CAST inhibition (Machado et al. 2015), 
suggesting a participation of calpains in neurogenesis. These seemingly contradictory 
effects can also be seen regarding cell migration, where calpain inhibition was shown 
to reduce migration of pancreatic beta-cells, vascular smooth muscle cells, T-cell and 
lung endothelial cells (Parnaud et al. 2005, Paulhe et al. 2001, Qiu et al. 2006, Rock et 
al. 2000), while also increasing neutrophil spreading ability (Lokuta et al. 2003). 
Furthermore, contradictory effects can be seen even in the same cell type, such as an 
increase or decrease in platelet spreading with calpain inhibition (Croce et al. 1999, 
Kuchay et al. 2012). Therefore, not only how calpains function in different cells but also 
what triggers their activity must be investigated with further detail, to account for these 
differences. 
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In addition to the physiologic roles of calpains, it is also interesting to evaluate their 
effects under pathologic conditions. After a brain lesion, there is overactivation of 
glutamate receptors, leading to an increase of calcium intake by the cells. Since 
calpains are activated by increased levels of Ca2+, it is also not surprising that they are 
involved in neuronal damage (Araujo et al. 2010). Deregulation of calpain activity has 
thus been implicated in several brain disorders, such as ischemic stroke, traumatic 
brain injury and Alzheimer’s, Parkinson’s and Huntington’s diseases, and calpain 
inhibition has shown potential in conferring neuroprotection (reviewed in(Saez et al. 
2006). Our group has also demonstrated that calpain inhibition is neuroprotective in a 
seizure-induced model of temporal lobe epilepsy (Araujo et al. 2008). Moreover, since 
calpains are implicated not only in cell proliferation and migration, but have also been 
reported to interfere with cell differentiation (Kashiwagi et al. 2010, Yajima & 
Kawashima 2002) and synaptic plasticity (Baudry & Bi 2016), it would be interesting to 
evaluate whether calpain inhibition could also enhance neurogenesis, being capable of 
helping regenerating the brain, in addition to being neuroprotective. 
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1.3. Objectives 
 
Calpains are known players in brain damage, and calpain inhibition is known to be 
neuroprotective in several neuronal disorders. These proteases are involved in the 
processes of cell proliferation, migration and differentiation in several systems, but not 
much is known of how they affect these processes during adult neurogenesis. Previous 
work by our group has shown that increased calpain activity impairs NSC proliferation 
in the DG and neuroblast migration both in the DG and in the RMS of adult mice. 
Moreover, calpain inhibition is able to enhance cell migration in SVZ explants. With this 
work, we proposed to further investigate the effects of calpains on neurogenesis, in 
order to determine how calpain modulation can contribute to enhance post-injury brain 
repair. We first wanted to evaluate whether the lack of CAST, the endogenous calpain 
inhibitor, also impaired SVZ-derived cell proliferation and migration in vitro, and, if that 
would be the case, whether calpain inhibition could reverse this impairment. Next, we 
used a model of seizure-induced neuronal lesion in mice overexpressing CAST, to 
assess the pattern of post-injury neurogenesis and cognitive recovery in these mice. 
Lastly, we used mice lacking one or both conventional calpains and evaluated whether 
absence of these calpains would affect early stages of hippocampal neurogenesis.  
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2.1. Animals 
  
In this study, we used several mouse lines that have different calpain or calpastatin 
(CAST) expression. Mice lacking CAST (Cast KO) (Takano et al. 2005) have 
polyadenylation signals in exon 6 to inhibit transcription of the calpain-inhibitory 
domains. Mice overexpressing CAST (hCAST) (Rao et al. 2008) have a human CAST 
construct (Hitomi et al. 1998) cloned into a Thymocyte differentiation antigen 1.1 
expression cassette. For calpain knockout animals, mice lacking calpain 1 (Capn1 KO), 
calpain 2 (Capn2 cKO) or both (Capn1&2 cDKO) were used. For Capn1 KO mice 
(Azam et al. 2001), a phosphoglycerate kinase-cassette replaces a portion of exon 4 
that belongs to a catalytic domain. Since conventional knockouts for calpain 2 are 
embryonically lethal (Dutt et al. 2006), a conditional knockout was used. Capn2 cKO 
mice (Takano et al. 2011) have therefore exon 3 flanked by LoxP sites, which can be 
recombined by Cre. Cre recombinase, in this case, is in turn under the control of the 
promoter of Nestin, in order to achieve knockout animals for calpain 2 in the CNS. 
Capn1&2 cDKO present both genotypes at the same time. All animals have been 
backcrossed in a C57BL/6J background, so C57BL/6J wild-type (WT) mice and WT 
littermates were used for comparison. To exclude the influence of the presence of Cre 
alone, animals that express Cre and express calpains 1 and 2 were also used as a 
comparison group (Cre Ctrl). The animals were kept in our animal facilities, at the 
Center for Neuroscience and Cell Biology (Coimbra) and at the University of Algarve 
(Faro), with food and water ad libitum in a 12-hour dark:light cycle. All experiments 
were performed in accordance with institutional and European guidelines (2010/63/EU) 
for the care and use of laboratory animals. 
 
2.1.2. Genotyping 
 
DNA from each animal was obtained from the limbs (newborn mice) or tail clips (adult 
mice) and purified using the QIAamp DNA mini kit or the NZY Tissue gDNA Isolation 
kit. The genotypes were confirmed by PCR, using Platinum® Taq DNA Polymerase 
and dNTP Mix (for Cast KO) or NZYTaq 2x Green Master Mix, with the primers and 
annealing temperatures (Ta) listed on Table 2.1. The PCR products were run in a 2% 
agarose gel with ethidium bromide or GreenSafe Premium and visualized in a Gel 
Doc™ XR+ or a ChemiDoc XRS imaging system (BioRad Laboratories Inc., Hercules, 
CA, USA).  
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Table 2.1 - Primers and annealing temperatures (Ta) used for genotyping. 
 Primers (5’ - 3’) Ta 
Cast KO 
TCCGAAGCACACATCAAGTACAGG 
54ºC CATTGCTCAGCGGTGCTGTCC 
TTCTGTGTAAAGAAGCAAAAGGCAGC 
hCAST 
AAGGCCATTCCAGTCAGCCA 
60ºC 
AGCAACACTCTCTCCAC 
GAPDH 
(housekeeping) 
ACCACAGTCCATGCCATCAC 
TCCACCACCCTGTTGCTG 
Cre 
CGCAGAACCTGAAGATGTTC 
CGAAATCAGTGCGTTCGAAC 
Capn1 KO 
CTCACTTAGCATAGGCTTTCTCCAGCAGTG 
CCTGAAGAACGAGATCAGCAGCCTCT 
CAGAACCACTGACACGGTCCAGATCTG 
Capn2 cKO 
ATAGCTCCTGTGTATCAGGCACAGAGCTGG 
64ºC 
GGAGCTCATCTGTGTCTCCAAAGCC 
  
2.2. Cell culture experiments 
 
2.2.1. SVZ cultures 
 
For the in vitro experiments, neural stem cells (NSCs) isolated from the subventricular 
zone (SVZ) of post-natal WT or Cast KO mice (0-3 days old) were used, prepared as 
previously described (Morte et al. 2013). Mice were decapitated and the brains 
removed and placed in a solution of 0.24% gentamicin in Hank’s balanced salt solution 
(HBSS), where the meninges were removed. The brains were cut in 1 mm thick slices 
in a matrix and the SVZ was isolated under a stereomicroscope (Stemi DV4, Zeiss, 
Oberkochen, Germany), placed in clean 0.24% gentamicin/HBSS and digested with 
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0.025% trypsin/0.265 mM ethylenediaminetetraacetic acid (EDTA), for 15 min at 37ºC. 
After washing three times with 0.24% gentamicin/HBSS, the tissue was resuspended 
and the cells mechanically dissociated in warm Dulbecco’s modified eagle medium: 
nutrient mixture F-12 (D-MEM/F-12) with 2 mM GlutaMAX™-I (L-Ala-L-Gln), 
supplemented with 1% B27, 1% antibiotic (10,000 units/ml of penicillin, 10 mg/ml 
streptomycin), 10 ng/ml epidermal growth factor (EGF) and 5 ng/ml basic fibroblast 
growth factor (FGF), and plated on uncoated flasks with filter cap, 100,000 cells/ml, in 
supplemented D-MEM/F-12/GlutaMAX™-I medium. These cells were maintained in 
culture as floating aggregates, neurospheres (Fig. 2.1), in a 95% air/5% CO2 humidified 
atmosphere at 37ºC, and passaged at least once a week, by letting the neurospheres 
sediment, mechanically dissociate them and re-plating in new supplemented medium. 
Whenever possible, NSCs with at least two and up to twelve passages were used for 
these experiments. 
 
 
 
Figure 2.1 - Floating neurospheres. Cells isolated from the SVZ of post-natal mice in 
culture, as neurospheres. Scale bar: 100 µm. 
 
2.2.2. αII-spectrin breakdown analysis 
 
To analyze αII-spectrin breakdown products, neurospheres were collected, gently 
dissociated and plated on 0.1 mg/ml poly-L-lysine-coated plates, in supplemented 
medium, until at least 70% confluency was reached (Fig. 2.2). The NSCs were then 
treated with the calcium ionophore A23187 10 µM for 1h30 and the levels of full-length 
αII-spectrin and its breakdown products detected by Western blot (Sengoku et al. 
Chapter 2 
 
24 
 
2004). For that purpose, the medium was removed, and after washing once with 0.01 
M phosphate buffer saline (PBS), cytosolic cell extracts were prepared by lysing the 
cells in 100 mM Tris-HCl, 10 mM ethylene glycol tetraacetic acid, 1% triton X-100 and 2 
mM MgCl2, pH 7.4, supplemented with 1x PhosSTOP phosphatase inhibitors, 1x 
cOmplete, Mini protease inhibitors and 1 μM dithiothreitol, at 4ºC. The lysates obtained 
were then sonicated 6 times with 2-second pulses, 4 seconds apart, and centrifuged for 
10 min, 15,800 g, at 4ºC. The protein concentration in the supernatant was determined 
by the bicinchoninic acid method, using the BCA protein kit, according to the 
manufacturer’s instructions. 6x concentrated sample buffer was added (0.5 M Tris-
HCl/0.4% sodium dodecyl sulfate (SDS) pH 6.8, 30% glycerol, 10% SDS, 0.6 M 
dithiothreitol, 0.012% bromophenol blue) and the lysates were denatured at 95ºC for 5 
min. Equal amounts of protein (15 μg) were separated by electrophoresis on SDS-
polyacrylamide gels, using MiniPROTEAN® 3 systems (BioRad Laboratories Inc., 
Hercules, CA, USA). Electrophoresis gels composition was 6% bis-acrilamide in 1.5 M 
Tris-HCl pH 8.0 (for the resolving gel) and 4% bis-acrilamide in 0.5 M Tris-HCl pH 6.8 
(for the stacking gel), plus 0.1% SDS, 0.05% tetramethylethylenediamine and 0.05% 
ammonium persulfate, in ultrapure water. Gels were submerged in running buffer (25 
mM Tris, 25 mM bicine, 0.1% SDS, pH 8.3), the samples loaded onto the gel and the 
electrophoresis started at 60 V for 10 min, followed by 140 V until proper band 
separation was achieved. Polyvinylidene difluoride membranes were activated in 100% 
methanol for about 5 s and for 15-30 min in electrotransfer buffer (N-cyclohexyl-3-
aminopropanesulfonic acid 10 mM, methanol 10%, pH 11.0) and the proteins were 
then transferred electrophoretically (350 mA for 1 h) to the membranes, submerged in 
electrotransfer buffer, using a MiniPROTEAN® Tetra Cell apparatus (BioRad 
Laboratories Inc., Hercules, CA, USA). Membranes were blocked for 1 h at room 
temperature, in Tris buffer saline (137 mM NaCl, 20 mM Tris-HCl, pH 7.6) containing 
0.1% tween-20 (TBS-T) and 5% low-fat dry milk. Incubations with the primary 
antibodies (mouse anti-αII-spectrin 1:2,000 and mouse anti- glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) 1:5,000 for the loading control, in TBS-T with 1% 
low-fat dry milk) were performed overnight, at 4ºC. The membranes were then washed 
in TBS-T (three 5 min washes, with 2 quick washes before and after) and incubated for 
1 h, at room temperature, with the correspondent horseradish peroxidase-conjugated 
secondary antibody (anti-mouse 1:2,000 in TBS-T with 1% low-fat dry milk). 
Membranes were washed again in TBS-T, incubated 5 min with the Clarity™ Western 
ECL substrate and bands were then visualized in a ChemiDoc XRS imaging system, 
using the ImageLab software (version 4.0), from BioRad Laboratories Inc. (Hercules, 
CA, USA). 
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Figure 2.2 - Plated NSCs. Dissociated cells isolated from the SVZ of post-natal mice, 
plated on a poly-L-lysine-coated well. Scale bar: 200 µm. 
 
2.2.3. Cell proliferation 
 
For cell proliferation assays, dissociated NSCs were plated on 0.1 mg/ml poly-L-lysine-
coated glass coverslips and kept in culture, in supplemented medium, until 40-60% 
confluency was reached. The cells were left untreated or were treated with calpeptin 25 
μM for 6 h and fixed with 4% paraformaldehyde/4% sucrose in PBS. 5-ethynyl-2’-
deoxyuridine (EdU) 10 μM was given to the cells 4 h before fixation and its detection 
was performed using a commercially available kit (Click-iT® EdU Alexa Fluor® 488 
HCS Assay). The cells were rinsed with 3% bovine serum albumin (BSA) in PBS, 
permeabilized with 0.5% triton X-100 in PBS for 15 min at room temperature and a 
reaction cocktail (reaction buffer, CuSO4, Alexa Fluor 488 and reaction buffer additive) 
was added for 30 min, at room temperature, protected from light. After rinsing again in 
3% BSA, all nuclei were stained with 1 μg/ml Hoechst 33342 for 5 min, the cells 
washed in PBS and the coverslips mounted in slides with DAKO fluorescence 
mounting medium, as previously described (Morte et al. 2013). EdU-positive cells from 
3-6 independent experiments were counted in 10 images per sample, acquired in an 
Axio Imager Z2 microscope (Zeiss, Oberkochen, Germany). 
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2.2.4. Cell migration 
 
Regarding cell migration in vitro, three different methods were used: radial migration, 
wound healing assays and time-lapse imaging. 
 
2.2.4.1. Radial migration 
 
In the radial migration method, neurospheres of similar sizes were plated on 0.1 mg/ml 
poly-L-lysine- and 10 µg/ml laminin-coated glass coverslips, in supplemented medium. 
The cells were fixed with 4% paraformaldehyde/4% sucrose after 4 h, and the 
coverslips were mounted in slides with DAKO fluorescence mounting medium. Phase 
contrast images from 3 independent experiments were acquired in an Axio Imager Z2 
microscope (Zeiss, Oberkochen, Germany) and the migration radia of the 5 furthest 
cells from 20 neurospheres (Fig. 2.3) in each sample were measured (Gu et al. 2009), 
using the AxioVision Rel. 4.8 software (Zeiss, Oberkochen, Germany). 
 
 
 
Figure 2.3 - SVZ-derived cells migrating out of a neurosphere in the radial 
migration assay. Cells isolated from the SVZ of post-natal mice, 4 h after being plated 
as a neurosphere on a poly-L-lysine- and laminin-coated coverslip. The 5 furthest cells 
are indicated with the black arrowheads. Scale bar: 100 µm. 
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2.2.4.2. Wound healing assay 
 
For the wound healing assay, the cells were dissociated and plated on poly-L-lysine- 
and laminin-coated dishes, in supplemented medium, until completely confluent. A 
layer of cells was then removed in the middle, by scratching the bottom of the dish with 
a 10 µl pipette tip (Liang et al. 2007), across the dish (Fig. 2.4), and the area of cells 
that migrated towards the gap was measured in 4-6 independent experiments after 3 
and 6 h, in phase contrast images acquired in an Axiovert 40 CFL microscope (Zeiss, 
Oberkochen, Germany). 
 
 
 
Figure 2.4 - Gap of confluent NSCs in the wound healing assay. Confluent cells 
isolated from the SVZ of post-natal mice, plated on a poly-L-lysine- and laminin-coated 
dish, with a cell layer removed in the middle, for the wound healing assay. Scale bar: 
200 µm. 
 
2.2.4.3. Time-lapse imaging 
 
Lastly, for the time-lapse imaging assay, neurospheres were plated on poly-L-lysine- 
and laminin-coated chambered wells, in Krebs media (2 M NaCl, 500 mM KCl, 1 M 
MgCl2, 1 M CaCl2, 500 mM glucose, 500 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid, pH 7.4). Images from 3 independent experiments were 
taken every 3 minutes for 4 h, at 37ºC, using a DeltaVision® Core inverted microscope 
(GE Healthcare, Little Chalfont, UK) (Fig. 2.5). Cells belonging to the first batch of cells 
migrating out of 3 neurospheres (38-52 cells each) per sample were tracked (Machado 
et al. 2015) and the migration speed and frequencies distributions were determined, 
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using the ImageJ (version 1.47v, National Institutes of Health, Bethesda, MD, USA) 
plugin MTrackJ. 
 
 
 
Figure 2.5 - SVZ-derived cells migrating out of a neurosphere in the time-lapse 
imaging assay. Cells isolated from the SVZ of post-natal mice, plated as a 
neurosphere on a poly-L-lysine- and laminin-coated chambered well. Example of the 
tracking of one cell in yellow. Scale bar: 100 µm. 
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2.3. In vivo experiments  
 
2.3.1. Presence of CAST and CAPN2 in hippocampal lysates 
 
To obtain hippocampal lysates, mice were sacrificed by cervical displacement, the 
brains removed and the hippocampi isolated and rapidly frozen in liquid nitrogen. Lysis 
buffer (50 mM Tris-HCl, 0.5% triton X-100, pH 7.4), supplemented with 1x PhosSTOP 
phosphatase inhibitors, 1x cOmplete, Mini protease inhibitors and 1 μM dithiothreitol, 
was added and the samples were homogenized in a Mini Potter tissue grinder 
(Jencons Scientific Ltd., Leighton Buzzard, UK), on ice. The lysates were then 
sonicated 4 times with 2-second pulses, 6 seconds apart, on ice, using a  Vibra-cell™ 
VCX130 ultrasonic processor (Sonics, Newtown, CT, USA), and centrifuged for 10 min, 
15,800 g, at 4ºC, to isolate the cytosolic fraction. Determination of protein concentration 
and Western blot analysis were performed similarly to section 2.2.2. Equal amounts of 
protein (7 μg for CAST and 15 μg for CAPN2) were separated in 10% bis-acrilamide 
resolving gels, and the primary antibodies used were rabbit anti-CAST 1:200, rabbit 
anti-CAPN2 1:1,000 and mouse anti-GAPDH 1:5,000 (loading control), followed by the 
correspondent horseradish peroxidase-conjugated secondary antibodies (anti-rabbit or 
anti-mouse 1:2,000). 
 
2.3.2. Hippocampal neurogenesis and behavior under pathological conditions  
 
2.3.2.1. Kainic acid (KA) treatment 
 
For the studies of post-injury neurogenesis, 3 month old WT and hCAST mice were 
used. Hippocampal damage was induced by administering kainic acid (KA) 
subcutaneously (s.c., 25 mg/kg, in a saline (SAL) solution of 0.9% NaCl), as previously 
described by our group (Carreira et al. 2010). After KA administration, the animals went 
through several stages, according to a well defined scale (Schauwecker & Steward 
1997): immobility (I), tail/forelimb extension / rigid posture (II), repetitive movements / 
head bobbing (III), rearing and falling (IV), continuous rearing and falling (V), severe 
tonic-clonic seizures (VI). Only mice that reached stage V or higher were used in this 
study. SAL-treated animals were used as controls. 
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2.3.2.2. NSC proliferation 
 
Cell proliferation after KA or SAL treatment was assessed as shown in Fig. 2.6. WT 
and hCAST mice were given either KA or SAL subcutaneously and, on day 5, when a 
peak of proliferation was seen to occur in the dentate gyrus (DG) after KA treatment 
(Carreira et al. 2010), BrdU (5-bromo-2’-deoxyuridine) was administered 
intraperitoneally (i.p., 4 doses of 50 mg/kg, 2 h apart), up to 12 h before sacrifice by 
transcardial perfusion.  
 
 
 
Figure 2.6 - Experimental procedure for the study of NSC proliferation after KA or 
SAL treatment. WT and hCAST mice were treated with either SAL or KA (25 mg/kg, 
s.c.) and on day 5 were given BrdU (4 doses of 50 mg/kg, i.p.), up to 12 h before 
sacrifice.  
 
2.3.2.3. Neuroblast migration 
 
In order to investigate neuroblast migration after lesion, WT and hCAST mice were 
given either KA or SAL subcutaneously and sacrificed by transcardial perfusion, after 
14 days, when an increase in cell migration is known to occur in the DG after KA 
treatment (Carreira et al. 2015) (Fig. 2.7). 
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Figure 2.7 - Experimental procedure for the study of neuroblast migration after 
KA or SAL treatment. WT and hCAST mice were treated with either SAL or KA (25 
mg/kg, s.c.) and sacrificed after 14 days.  
 
2.3.2.4. Neuronal differentiation and behavior analysis 
 
To assess neuronal differentiation and long-term behavioral recovery after lesion, WT 
and hCAST mice were treated as shown in Fig. 2.8. EdU was administered to WT and 
hCAST mice on days 3, 4 and 5 after KA or SAL treatment, and the animals were 
sacrificed by transcardial perfusion after 8 weeks, when new neurons are fully mature 
(Aimone et al. 2014). During the last week, three different behavioral tests were 
performed: object recognition, using open field as the habituation step, water maze and 
fear conditioning, as explained further in more detail. For the studies of short-term 
behavioral recovery, the same behavioral tests were performed on WT and hCAST 
mice, 2 weeks after KA or SAL treatment (Fig. 2.9). 
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Figure 2.8 - Experimental procedure for the study of neuronal differentiation and 
long-term behavioral recovery after KA or SAL treatment. WT and hCAST mice 
were treated with either SAL or KA (25 mg/kg, s.c.) and, on days 3, 4 and 5, were given 
EdU (50 mg/kg, i.p.), 8 weeks before sacrifice. During the last week, the cognitive 
behavior of the animals was tested. On the first day, open field (OF) and object 
recognition (OR) performance were tested. Water maze (WM) trials were performed on 
the next 3 days and the final test, without the platform, was on day 4. On the next day, 
fear conditioning (FC) trials were performed. One day later, the animals were at first left 
on the same context and after 3 h the context was completely modified and the cued 
test performed. The animals were sacrificed on the next day. 
 
 
 
 
Figure 2.9 - Experimental procedure for the study of short-term behavioral 
recovery after KA or SAL treatment. WT and hCAST mice were treated with either 
SAL or KA (25 mg/kg, s.c.) and, after 2 weeks, the cognitive behavior of the animals 
was tested. On the first day, open field (OF) and object recognition (OR) performance 
were tested. Water maze (WM) trials were performed on the next 3 days and the final 
test, without the platform, was on day 4. On the next day, fear conditioning (FC) trials 
were performed. One day later, the animals were at first left on the same context and 
after 3 h the context was completely modified and the cued test performed. The 
animals were sacrificed on the next day. 
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2.3.2.4.1. Open field and object recognition 
 
For the study of recognition memory, the object recognition test (Bevins & Besheer 
2006) was used (Fig. 2.10). Mice were presented to two similar objects (Fig. 2.10B), 
following habituation to the apparatus (40x40x40 cm acrylic box) (Fig. 2.10A), after 
which one of the objects was replaced by a novel one (Fig. 2.10C). Each stage of the 
test had the duration of 5 min, 2 h apart, and the apparatus and objects were cleaned 
with 10% ethanol between animals. In the habituation period, we also took the 
opportunity to perform the open field test (Gould et al. 2009), by dividing the base of 
the apparatus into nine equal squares and observing the overall locomotor activity (line 
crossings and rearing episodes) and anxiety behavior (central entries and time in 
center) of these animals. In the presence of the objects, the percentage of time spent 
with each object (totalizing 100%) was measured. The analysis was done in videos 
acquired with a GoPro Hero (GoPro, Inc., San Mateo, CA, USA) during testing, of 12-
16 independent experiments in the long-term group and 3-5 independent experiments 
in the short-term group, using the Any-maze software (version 4.99, Stoelting Co., 
Wood Dale, IL, USA). 
 
 
 
Figure 2.10 - Object recognition test. Representative images showing the apparatus 
(40x40x40 cm acrylic box) for the object recognition test. Each stage had the duration 
of 5 min, 2 h apart. (A) Habituation/open field. (B) First object presentation. (C) 
Presentation to novel object. 
 
2.3.2.4.2. Water maze 
 
To evaluate spatial learning and memory, the water maze test (Morris et al. 1982) was 
performed. During the first 3 days, the animals were trained to find a platform (10 cm 
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diameter, carved to increase grip) hidden 0.5 cm below the water surface level in a 
circular pool (1.52 m diameter), in a fixed location. Visual cues on the walls around the 
pool were provided to help the mice locating the platform and the water temperature 
was maintained at 22ºC ± 1ºC. The pool was divided into four quadrants (Fig. 2.11) 
and, on each day of training, the animals were placed in a different quadrant, always 
facing the border of the pool, under the course of four 60 s trials, 30 min apart. The 
latency to escape was measured as the time each animal took to find and climb onto 
the platform. If the animal did not reach the platform within the course of the trial, the 
latency to escape was considered 60 s and the animal was left on the platform for 10 s, 
in order to learn the platform location. On the last day of testing, the platform was 
removed and the mice were placed in the quadrant opposite to the target quadrant 
(where the platform was previously located), facing the border of the pool. The time 
spent on each quadrant and the number of crossings over the previous platform 
location were measured for 60 s, to see if the animals remembered where the platform 
was located during training. All animals were dried under an infrared light after each 
trial. The analysis was done in videos acquired with a GoPro Hero (GoPro, Inc., San 
Mateo, CA, USA) during testing, of 11-16 independent experiments in the long-term 
group and 4-5 independent experiments in the short-term group, using the Any-maze 
software (version 4.99, Stoelting Co., Wood Dale, IL, USA). 
 
 
 
Figure 2.11 - Water maze test. Representative image showing the apparatus for the 
water maze test (1.52 m diameter pool). The platform remained on the same location 
during trials (3 days, 4 trials of 60 s per day, 30 min apart) and was removed on the 
fourth day (60 s test). 
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2.3.2.4.3. Fear Conditioning 
 
Lastly, associative learning and memory were tested by performing the fear 
conditioning test (Wehner & Radcliffe 2004). The first day of testing consisted of 
learning to associate a cue tone (80 dB) with a footshock (0.7 mA). For this part of the 
test, mice were placed in a chamber (17x17x25 cm) with a grid floor inside a 
soundproof box (Stoelting Co., Wood Dale, IL, USA), with a background white noise, 
70% ethanol scent and 100% lux lighting (context A), for 2 min 
(acquisition/habituation), after which the tone was played for 30 s and the footshock 
given during the last 2 s of tone. This was repeated 2 more times, after a 60 s rest. On 
the next day, the association of the context with the footshock was tested, by placing 
the mice inside the chamber in the same conditions as during learning for 5 min, 
without presentation of tone or footshock. After 3 h, we tested the association of the 
footshock with the tone (cued test), by placing the animals in a completely different 
environment for 3 min (habituation to new context) and then playing the tone for the 
last 3 min. The new context consisted of a background fan noise, vanilla scent, 10% lux 
lighting, and the previously used chamber was altered by using striped black and white 
walls and a white floor covering the grid (context B). During the whole fear conditioning 
testing, the chamber was cleaned with 10% ethanol between animals, and the fear 
behavior measured by calculating the percentage of freezing time, in 9-16 independent 
experiments in the long-term group and 3-5 16 independent experiments in the short-
term group, using the Any-maze software (version 4.99, Stoelting Co., Wood Dale, IL, 
USA). 
 
 
 
Figure 2.12 - Fear conditioning test. Representative images showing the apparatus 
for the fear conditioning test (17x17x25 cm chamber). (A) Context for trials (30 s 80 dB 
cue tone with a 0.7 mA shock on the last 2 s of tone, x3, 60 s apart, after 2 min 
habituation) and context test (5 min, on the next day). (B) Context for cued test (3 min 
habituation followed by 3 min tone, 3 h after context). 
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2.3.3. Early hippocampal neurogenesis under physiological conditions 
 
To study the influence of calpains on neurogenesis in physiological conditions, WT, 
Capn1 KO, Capn2 cKO, Capn1&2 cDKO and Cre Ctrl mice were treated with  BrdU (50 
mg/kg, i.p., twice, daily) for 3 days and, after 7 days, with EdU (50 mg/kg, i.p., twice, 2 
h apart) (Fig. 2.13). The animals were sacrificed by transcardial perfusion on the next 
day, in order to access cell proliferation and migration (Machado et al. 2015). 
 
 
 
Figure 2.13 - Experimental procedure for the study of NSC proliferation and 
neuroblast migration. WT, Capn1 KO, Capn2 cKO, Capn1&2 cDKO and Cre Ctrl 
mice were treated with 50 mg/kg BrdU (i.p., twice, daily) for 3 days and, after 7 days, 
with 50 mg/kg EdU (i.p., twice, 2 h apart). The animals were sacrificed on day 12.  
 
2.3.4. EdU detection and immunohistochemistry 
 
Brains used for immunohistochemistry and EdU detection were obtained after 
transcardial perfusion of the mice with 0.9% NaCl and 4% paraformaldehyde, following 
anesthesia with Avertin (12.5 mg/ml 2,2,2-tribromoethanol, 2.5% 2-methyl-2-butanol). 
The brains were removed and kept in 4% paraformaldehyde overnight for further 
fixation and then dehydrated in 20% sucrose in phosphate buffer for at least one day, 
all at 4ºC. Coronal sections from the hippocampal region were cryosectioned (30 µm 
thick, in 6-series) using a CryoStar NX50 cryostat (Thermo Fisher Scientific, Waltham, 
MA, USA) and stored in an antifreeze solution (30% ethylene glycol and 30% glycerol 
in phosphate buffer), at 4ºC. Free-floating brain sections from one of the series were 
labeled against CAST, BrdU, doublecortin (DCX), BrdU/DCX, EdU or EdU/NeuN 
(neuronal nuclei), as previously described (Machado et al. 2015, Morte et al. 2013). 
EdU labeling was performed using a commercially available kit (Click-iT® EdU Alexa 
Fluor® 488 HCS Assay). After rinsing with 3% BSA, the sections were permeabilized 
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with 0.5% triton X-100 for 45 min, rinsed again and then incubated with a reaction 
cocktail (reaction buffer, CuSO4, Alexa Fluor 488 and reaction buffer additive) for 1 h, 
protected from light, all at room temperature. For immunohistochemistry, sections were 
rinsed with PBS and then blocked for 1 h, at room temperature, in 5% blocking solution 
in 0.25% triton X-100, using normal goat or horse serum, according to the secondary 
antibodies used. After blocking, the sections were kept with the primary antibodies 
(rabbit anti-CAST 1:250, rat anti-BrdU 1:50, goat anti-DCX 1:400, mouse anti-NeuN 
1:200) for 48 h, at 4ºC. Sections were then rinsed in 2% blocking solution and 
incubated for 2 h, at room temperature and protected from light, with the correspondent 
Alexa Fluor-conjugated secondary antibodies (goat anti-rabbit 488, donkey anti-rat 488, 
donkey anti-goat 594, goat anti-mouse 633 and donkey anti-mouse 594; 1:200). For 
the labeling of BrdU, a DNA denaturation step with 1 M HCl for 20 min, at 65ºC, was 
performed in the beginning. In the cases where NeuN was not labeled, nuclei were 
stained with 2 μg/ml Hoechst 33342 for 10 min, at room temperature. When the 
combination of EdU and NeuN was needed, the EdU labeling was performed, followed 
by the immunohistochemistry, starting with the blocking step. The entire procedure was 
done using an orbital shaker. After a final rinsing step, the sections were mounted in 
gelatin-coated (0.5% gelatin with 0.5 mg/ml CrKO8S2.12H2O) slides with DAKO 
fluorescence mounting medium. 
 
2.3.5. Analysis of incorporation of BrdU and EdU 
 
BrdU-positive and EdU-positive cells in the SGZ, the first layer of cells adjacent to the 
hilus, in the granular zone (GZ) or in the hilus (Fig 2.14) of 5 mid sections of the 
hippocampus were counted for each animal (Machado et al. 2015, Salazar-Colocho et 
al. 2008), directly under an epifluorescence microscope (Axio Imager Z2 microscope, 
Zeiss, Oberkochen, Germany). Cell counting was carried out in both upper and lower 
blades of the DG, in 8-14 independent experiments for the pathological studies and 5-9 
independent experiments for the physiological studies. 
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Figure 2.14 - Section of the DG from a hippocampal brain slice. Representative 
image of a section of the DG, showing the division into GZ, SGZ and hilus. EdU in 
green and nuclei, stained for Hoechst 33342, in grey. Scale bar: 50 µm. 
 
2.3.6. DCX immunoreactivity and migration measurements 
 
DCX immunoreactivity in the DG and migration distances of BrdU-positive/DCX-
positive cells in the GZ were determined in images acquired in a laser scanning 
microscope (LSM710, Zeiss, Jena, Germany), in 6-9 independent experiments. The 
quantification of the DCX-positive area was performed in ImageJ (version 1.47v, 
National Institutes of Health, Bethesda, MD, USA), using a threshold analysis in 5 mid 
sections of the hippocampus of each animal. This consisted in defining the optimal 
staining threshold and calculating the area labeled with DCX (Komitova et al. 2005, 
Machado et al. 2015). The migration measurements, in turn, were performed in a total 
of at least 33 cells per group, from 5 images acquired for each animal, by determining 
the distance between the nucleus of the cell and the boundary between the SGZ and 
the hilus, perpendicularly to that delimitation (Machado et al. 2015), in 5-7 independent 
experiments, using the ZEN 2011 software (version 7.1, Zeiss, Jena, Germany). 
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2.3.7. Neuronal differentiation analysis  
 
For the quantification of newborn neurons, the percentage of cells labeled for both EdU 
and NeuN in the DG was determined in a total of up to 50 EdU-positive cells (Carreira 
et al. 2015), in 8 independent experiments, in images (orthogonal reconstructions of 
projections from 0.73 µm z-stacks) acquired in a laser scanning microscope (LSM710, 
Zeiss, Jena, Germany). 
 
2.4. Statistical analysis 
 
Data are expressed as means ± SEM. Statistical significance was determined using a 
two-tailed t-test, a one-way or two-way analysis of variance (ANOVA, with Bonferroni’s 
post-test), as appropriate and indicated in the figure legends, using the GraphPad 
Prism 5 software (GraphPad Software, Inc., La Jolla, CA, USA). Differences were 
considered significant when p<0.05. 
 
2.5. Materials 
 
QIAamp DNA mini kit was acquired from Quiagen (Hilden, Germany), CAST KO 
primers from TIB MOLBIOL GmbH (Berlin, Germany), and NZY Tissue gDNA Isolation 
kit, the remaining primers, NZYTaq 2x Green Master Mix, agarose, GreenSafe 
Premium, Tris, NaCl, dithiothreitol, bis-acrilamide, tetramethylethylenediamine, 
ammonium persulfate, ECL and BSA were all bought from NZYTech (Lisboa, Portugal). 
Platinum® Taq DNA Polymerase, dNTP Mix, gentamicin, tripsin-EDTA, D-MEM/F-12 
with GlutaMAX™-I, penicillin/streptomycin, B27, BCA protein kit, EdU, Click-iT® EdU 
Alexa Fluor® 488 HCS Assay Kit, Hoechst 33342, all Alexa Fluor-conjugated 
secondary antibodies, slides and glass coverslips were acquired from Thermo Fisher 
Scientific (Waltham, MA, USA). Ethidium bromide, HBSS, poly-L-lysine, ethylene glycol 
tetraacetic acid, MgCl2, glycerol, bicine, N-cyclohexyl-3-aminopropanesulfonic acid, 
methanol, tween-20, BrdU, paraformaldehyde, CaCl2, 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid, 2,2,2-tribromoethanol, 2-methyl-2-butanol, ethylene 
glycol, HCl and CrKO8S2.12H2O were bought from Sigma Aldrich (St Louis, MO, USA). 
The matrix used was from Stoelting Co. (Wood Dale, IL, USA), EGF and FGF were 
Chapter 2 
 
40 
 
from PeproTech (London, UK), A23187 from Enzo Life Sciences, Inc. (Farmingdale, 
NY, USA) and low-fat dry milk from Nestlé (Vevey, Switzerland). Triton X-100, 
bromophenol blue, sucrose, KCl, glucose and gelatin were all obtained from Merck 
(Darmstadt, Germany), and SDS, another ECL and the primary antibody rat anti-BrdU 
were purchased from Bio-Rad Laboratories Inc. (Hercules, CA, USA). PhosSTOP 
phosphatase inhibitors, cOmplete, Mini protease inhibitors and laminin were obtained 
from Roche Applied Science (Penzberg, Germany), DAKO fluorescence mounting 
medium from Agilent Technologies (Glostrup, Denmark), Calpeptin from Tocris 
Bioscience (Bristol, UK), KA from Ocean Produce International (Shelburne, Canada), 
and normal goat and horse serums from Vector Laboratories Inc. (Burlingame, CA, 
USA). Polyvinylidene difluoride membranes and the primary antibodies mouse anti-αII-
spectrin, mouse anti-GAPDH and mouse anti-NeuN were acquired from Merck 
Millipore (Billerica, MA, USA), the horseradish peroxidase-conjugated secondary 
antibodies and the primary antibody rabbit anti-CAPN2 from Cell Signaling Technology 
(Danvers, MA, USA). Primary antibodies rabbit anti-CAST and goat anti-DCX were 
purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA), and rat anti-BrdU 
was acquired from (Oxford, UK). The pool used for the behavior experiments was from 
Bestway Inflatables & Material Corp. (Shanghai, China), the platform and acrylic box 
were made to measure at University of Algarve, the objects used were commonly used 
cardboard coffee cups and the lid from a small cardboard box, and the vanilla scent 
was diluted commercially available vanilla essence (Auchan, Croix, France). Ethanol 
was acquired from Panreac Química S.L.U. (Barcelona, Spain). 
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Chapter 3              
Effects of calpastatin modulation on physiological or post-injury neurogenesis 
and behavior 
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3.1. Summary 
 
In the adult mammalian brain, new neurons continue to be produced throughout life, in 
two main regions in the brain, the subgranular zone in the hippocampus and the 
subventricular zone in the walls of the lateral ventricles. Neural stem cells proliferate in 
these niches, and migrate as neuroblasts, to further differentiate in locations where 
new neurons are needed, either in normal or pathological conditions. However, this 
endogenous attempt of brain repair is not very efficient, since newborn cells may be 
lost or fail to integrate correctly in the existing neuronal network. Calpains are 
proteases known to be involved in the neuronal damage that occurs after brain injury 
and calpain inhibition has proven to be able to afford neuroprotection. These proteases 
are involved in cell proliferation, migration and differentiation of several cell types, 
though their effects on neurogenesis are not well known. Previous work by our group 
has shown that the absence of calpastatin, the endogenous inhibitor of calpains, 
impairs early stages of neurogenesis. In the present work, we show that impairment of 
NSC proliferation in these mice can be reversed with a calpain inhibitor, corroborating 
their relevance to the process, and the potential of calpain inhibition for the 
enhancement of neurogenesis. We further evaluated whether calpastatin 
overexpression would help improve efficiency of post-injury neurogenesis and cognitive 
recovery, in a model of seizure-induced hippocampal lesion. Enhancement of post-
injury neurogenesis was mostly maintained in these mice, though results from cognitive 
recovery seem to corroborate the neuroprotection granted by calpain inhibiton. 
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3.2. Introduction 
 
Adult mammalian neurogenesis is known to occur in two main regions in brain, the 
subventricular zone (SVZ), in the walls of the lateral ventricles, and the subgranular 
zone (SGZ), in the dentate gyrus (DG) of the hippocampus (Bond et al. 2015). Neural 
stem cells (NSCs) from the SVZ migrate long distances, through a rostral migratory 
stream (RMS), into the olfactory bulb, differentiating into interneurons, while NSCs from 
the SGZ migrate shorter distances into the granular zone (GZ), where they fully mature 
into granule neurons after 2 months (Aimone et al. 2014, Jin 2016). Functions of these 
newborn cells from both regions have been consistently associated with learning and 
memory (Deng et al. 2010, Lazarini & Lledo 2011). 
When a brain lesion occurs, adult neurogenesis can become altered. In 
neurodegenerative diseases, it is mostly hampered, but in acute disorders, such as 
temporal lobe epilepsy, NSC proliferation can increase, in a possible attempt to repair 
the damage. However, this repair is limited by impaired cell migration or decreased 
survival of new neurons (Kaneko & Sawamoto 2009, Ma et al. 2009). Discovering how 
to increase the efficiency of post-injury neurogenesis may therefore be beneficial for 
brain repair. 
Another feature of brain damage is excitotoxicity, which leads to an increase of cellular 
levels of calcium, activating several proteases, including calpains (Neumar et al. 2001). 
Calpains are ubiquitously expressed calcium-activated proteases, with only one known 
natural endogenous inhibitor, a protein called calpastatin (CAST) (Murachi 1984). In 
the CNS, calpain inhibition has been shown to afford neuroprotection, limiting neuronal 
damage and showing improved neuronal function in several brain disorders (Saez et al. 
2006). In other systems, calpains were seen to be involved in cell proliferation, 
migration and differentiation (Kashiwagi et al. 2010, Kuchay et al. 2012, Lokuta et al. 
2003, Parnaud et al. 2005, Qiu et al. 2006, Rock et al. 2000, Shimada et al. 2008, 
Yajima & Kawashima 2002), though little is known about their contribution to 
neurogenesis.  
Previous studies by our group show that increased calpain activity, through lack of 
CAST (Cast KO), can impair early stages of neurogenesis (Machado et al. 2015), and 
also that the kainic acid (KA) model of seizure-induced hippocampal lesion presents 
excitotoxic damage mediated by calpains (Araujo et al. 2008) and is characterized by a 
pathologic increase of hippocampal neurogenesis (Carreira et al. 2010). Thus, we 
proposed to assess whether calpain inhibition could reverse the impairment of early 
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stages of neurogenesis in the absence of CAST, and also whether overexpression of 
CAST (hCAST) could improve neurogenesis and cognitive recovery after KA-induced 
hipppocampal lesion.  
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3.3. Results 
 
3.3.1. Effects of CAST depletion on early neurogenesis in vitro 
 
3.3.1.1. CAST depletion translates into increased calpain activity in NSCs 
 
For the studies of the effects of CAST depletion on early neurogenesis, Cast KO mice 
were genotyped (Fig. 3.1A) and the absence of CAST in these mice was confirmed in 
brain sections, by comparison with wild-type (WT) (Fig. 3.1B,D). Negative controls (Fig. 
3.1C,E) corroborate the lack of CAST staining in Cast KO brain sections. 
Since calpains cleave αII-spectrin into specific fragments of 145 kDa and 150 kDa, 
distinguishable from caspase 3 activation, which generates a specific 120 kDa 
fragment (Wang 2000), we checked whether CAST depletion translated into increased 
calpain activity by treating NSCs with the calcium ionophore A23187 and observing the 
levels of αII-spectrin and its breakdown products. In the absence of the calcium 
ionophore, basal calpain activity does not seem to be increased in NSCs from Cast KO 
mice, since αII-spectrin breakdown products are not observed.. However, when treated 
with A23187, these cells presented increased levels of calpain-specific αII-spectrin 
breakdown products, in conditions that do not increase calpain activity in WT cells (Fig. 
3.2). 
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Figure 3.1 - Genotyping profiles and absence of CAST in Cast KO mice. 
Genotyping profiles of WT, Cast KO and Cast Ht mice (A). Representative images from 
hippocampal brain sections of WT (B) and Cast KO (D) mice, and respective negative 
controls (C, E), showing CAST in grey. Scale bar: 50 µm.  
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Figure 3.2 - CAST depletion translates into increased calpain activity after 
challenging NSCs with A23187. Western blot analysis of lysates of SVZ-derived 
NSCs from WT and Cast KO mice after treatment with A23187 10 µM for 1h30, to 
detect levels of full-length αII-spectrin and αII-spectrin breakdown products. GAPDH 
was used as a loading control. 
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3.3.1.2. CAST-depleted NSCs have impaired proliferation, which can be rescued 
by calpain inhibition 
 
To analyze the effects of CAST depletion on cell proliferation, NSCs were treated with 
5-ethynyl-2’-deoxyuridine (EdU), a thymidine analogue that incorporates the DNA of 
dividing cells (Chehrehasa et al. 2009). We observed that cell proliferation, assessed 
by the percentage of cells positive for EdU, was decreased in Cast heterozygous cells 
(Cast Ht; 17.0 ± 1.4%, p<0.05), and was even more impaired in Cast KO cells (9.2 ± 
1.0%, p<0.001), when compared with cells from WT mice (23.9 ± 2.3%) (Fig. 3.3), 
indicating a progressive decrease of cell proliferation with increased calpain activity. 
 
 
Figure 3.3 - CAST deficiency impairs NSC proliferation. SVZ-derived NSCs from 
post-natal WT, Cast Ht or Cast KO mice were plated on poly-L-lysine-coated glass 
coverslips and kept with EdU for 4 h. Representative images of cells from WT (A), Cast 
Ht (B) and Cast KO (C) mice, showing EdU-positive cells in green and nuclei, labeled 
for Hoechst 33342, in grey. Scale bar: 20 µm. Cell proliferation was calculated from 10 
images acquired for each sample and is presented as the percentage of living cells 
positive for EdU (D). Means ± SEM of 5-6 independent experiments were analyzed by 
a one-way ANOVA (Bonferroni’s post-test), *p<0.05 and ***p<0.001, significantly 
different from WT; +p<0.05 significantly different from Cast Ht. 
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Figure 3.4 - Calpain inhibition increases NSC proliferation of WT cells and 
rescues the proliferation of Cast KO cells. SVZ-derived NSCs from post-natal WT or 
Cast KO mice were plated on poly-L-lysine-coated glass coverslips, treated with 
calpeptin 25 µM for 6 h and kept with EdU for 4 h. Representative images of cells from 
WT (A, B) and Cast KO (C, D) mice, either untreated (A, C) or treated with calpeptin 25 
µM (B, D), showing EdU-positive cells in green and nuclei, labeled for Hoechst 33342, 
in grey. Scale bar: 20 µm. Cell proliferation was calculated from 10 images acquired for 
each sample and is presented as the percentage of living cells positive for EdU (E). 
Means ± SEM of 3 independent experiments were analyzed by a two-way ANOVA 
(Bonferroni’s post-test), *p<0.05 and **p<0.01, significantly different from control. 
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Moreover, the effect of calpain inhibition on cell proliferation was investigated, by 
treating NSCs from WT or Cast KO mice with the pharmacological calpain inhibitor 
calpeptin (25 µM). Calpain inhibition was shown to enhance NSC proliferation in both 
WT (32.0 ± 0.7%, p<0.05) and Cast KO (29.7 ± 0.8%, p<0.01) cells when compared to 
untreated cells (control; WT: 28.4 ± 1.0%, Cast KO: 24.2 ± 0.9%), thus reverting the 
proliferation impairment of cells lacking CAST. 
 
3.3.1.3. CAST depletion does not affect cell migration 
 
Regarding cell migration, three different approaches were used: radial migration 
analysis, wound-healing assay and time-lapse imaging. In the radial migration analysis, 
NSCs were plated as neurospheres and, after 4 h, the average migration radia of Cast 
KO cells leaving the neurospheres was similar to those of WT cells (262.1 ± 4.5 µm, 
p>0.05) (Fig. 3.5). 
 
 
Figure 3.5 - Depletion of CAST maintains cell migration (radial migration). SVZ-
derived NSCs from post-natal WT or Cast KO mice were plated as neurospheres on 
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poly-L-lysine and laminin-coated glass coverslips, for 4 h. Representative images of 
cells from WT (A) and Cast KO (B) mice, migrating out of the neurospheres. Scale bar: 
200 µm. Migration radia of 5 cells from 20 neurospheres per sample were measured in 
images acquired by phase contrast microscopy (C). Means ± SEM of 3 independent 
experiments were analyzed by a two-tailed t test, p>0.05.  
 
 
Figure 3.6 - Depletion of CAST maintains cell migration (wound-healing assay). 
SVZ-derived NSCs from post-natal WT or Cast KO mice were plated on poly-L-lysine 
and laminin-coated dishes until completely confluent, after which a layer of cells was 
removed. Representative images of the cell gaps after 0 h, 3 h and 6 h, for both 
genotypes (A). Scale bar 200 µm. Migration area was measured from images acquired 
by phase contrast microscopy, at 0, 3 and 6 h (B). Means ± SEM of 4-6 independent 
experiments were analyzed by a two-way ANOVA, p>0.05 between genotypes.  
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In the wound-healing assay, the area migrated by cells lacking CAST into the created 
gap was also similar to WT cells, at both time-points tested (3 h: 23,895.1 ± 8,241.4 
µm2, 6 h: 88,580.8 ± 12,926.2 µm2, p>0.05) (Fig. 3.6). 
 
Lastly, cells migrating out of plated neurospheres were tracked after time-lapse 
imaging (Fig. 3.7A), and the migration speed and frequency distributions were 
determined. Migration speed (Fig. 3.7B) also seemed to be maintained in CAST-
depleted cells in comparison to WT cells (50.5 ± 10.1 µm/h, p>0.05), as well as the 
frequency distributions of cells migrating at different paces (Fig. 3.7C).  
 
 
 
Figure 3.7 - Depletion of CAST maintains cell migration (time-lapse imaging). 
SVZ-derived NSCs from post-natal WT or Cast KO mice were plated as neurospheres 
on poly-L-lysine and laminin-coated wells and live imaged for 4 h, every 3 min. 
Representative image of the tracking of a cell migrating out of a neurosphere (A). Scale 
bar: 100 µm. Migration speed (B) and frequency distributions (C) were measured in 
cells belonging to the first batch of cells migrating out of 3 neurospheres (38-52 cells 
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each) per sample. Means ± SEM of 3 independent experiments were analyzed by a 
two-tailed t test (migration speed) or a one-way ANOVA (frequency distributions), 
p>0.05. 
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3.3.2. Effects of CAST overexpression on post-injury hippocampal neurogenesis 
and behavioral recovery 
 
3.3.2.1. CAST overexpression maintains enhancement of early hippocampal 
neurogenesis after KA treatment 
 
For the work in post-injury neurogenesis, hCAST mice were genotyped (Fig. 3.8A) and 
the overexpression of CAST in these mice was confirmed in hippocampal lysates, by 
comparison with WT. Levels of CAST from WT lysates were too low for detection, 
which was not the case for hCAST lysates, reflecting the increased levels of CAST in 
these mice (Fig. 3.1B). 
 
 
 
 
Figure 3.8 - Genotyping profiles and overexpression of CAST in hCAST mice. 
Genotyping profiles for WT and hCAST mice (A). Western blot analysis of hippocampal 
lysates from WT and hCAST mice (B), to detect overexpresison of CAST. GAPDH was 
used as a loading control. 
 
In order to study the effects of CAST overexpression on the early stages of 
hippocampal neurogenesis after a brain insult, NSC proliferation and neuroblast 
migration were analyzed in the DG of adult mice, after treatment with kainic acid. Cell 
proliferation was assessed by incorporation of the thymidine analogue 5-bromo-2’-
deoxyuridine (BrdU) into the DNA of dividing NSCs from the SGZ of the hippocampus. 
We observed that cell proliferation was greatly enhanced in mice overexpressing CAST 
after KA treatment (73.1 ± 8.0 cells/section), when compared to saline(SAL)-treated 
mice (19.2 ± 1.5 cells/section, p<0.001), similarly to what was seen in WT mice (KA: 
75.6 ± 9.7 cells/section, SAL: 25.0 ± 2.5 cells/section, p<0.001) (Fig. 3.9). 
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Figure 3.9 - KA-treated mice present increased NSC proliferation in the DG. WT 
and hCAST mice were treated with either SAL or KA and were given BrdU on the day 
before sacrifice, to assess cell proliferation. Representative images from hippocampal 
brain sections of SAL (A) and KA-treated (B) WT mice and SAL (C) and KA-treated (D) 
hCAST mice, showing BrdU-positive cells in white. Scale bar: 200 µm. BrdU-positive 
cells were counted in the SGZ of 5 mid hippocampal sections for each animal (E). 
Means ± SEM of 9-14 independent experiments were analyzed by a two-way ANOVA 
(Bonferroni’s post-test), ***p<0.001, significantly different from SAL.  
 
With regard to neuroblast migration, as assessed by doublecortin (DCX) staining in the 
DG, we also observed a significant increase in KA-treated mice overexpressing CAST 
(6.1 ± 0.6%), when compared to SAL-treated mice (1.9 ± 0.2%, p<0.001). Although cell 
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migration in the DG of KA-treated WT mice (8.5 ± 0.3%) was also enhanced in 
comparison with SAL (2.1 ± 0.2%, p<0.001), CAST overexpression seemed to 
attenuate this effect (Fig. 3.10). 
 
 
Figure 3.10 - KA treatment enhances neuroblast migration in the DG. WT and 
hCAST mice were treated with either SAL or KA and sacrificed after 14 days, to assess 
cell migration. Representative images from hippocampal brain sections of SAL (A) and 
KA-treated (B) WT mice and SAL (C) and KA-treated (D) hCAST mice, showing 
migrating neuroblasts, labeled for DCX, in white. Scale bar: 100 µm. Percentage of 
DCX-positive area was determined in the DG of 5 mid hippocampal sections for each 
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animal (E). Means ± SEM of 6-9 independent experiments were analyzed by a two-way 
ANOVA (Bonferroni’s post-test), ***p<0.001, significantly different from SAL.  
 
3.3.2.2. CAST overexpression maintains decrease in neuronal differentiation in 
the DG after KA treatment 
 
Besides cell proliferation and migration, we were also interested in investigating 
differentiation of newborn cells after treatment with KA. For that purpose, mice were 
treated with EdU, and the number of EdU-positive cells remaining in the DG after 8 
weeks was counted. We observed that the number of newborn cells still surviving in the 
DG was enhanced with KA-treatment, both in WT (SGZ+GZ: 9.7 ± 1.8 cells/section, 
hilus: 1.6 ± 0.3 cells/section) and hCAST (SGZ+GZ: 9.2 ± 1.1 cells/section, hilus: 1.6 ± 
0.3 cells/section) mice, when compared to SAL treatment (SGZ+GZ, WT: 1.8 ± 0.1 
cells/section, hCAST: 1.6 ± 0.3 cells/section, p<0.001; hilus, WT: 0.3 ± 0.1 
cells/section, p<0.01, hCAST: 0.6 ± 0.2 cells/section, p<0.05) (Fig. 3.11). 
However, when assessing neuronal differentiation specifically, by determining the 
percentage of those cells that colocalized with a neuronal marker (NeuN, neuronal 
nuclei), we could observe that treatment with KA reduced the amount of new neurons 
in the DG, both in mice overexpressing CAST (47.0 ± 4.1%) and in WT mice (52.5 ± 
8.0%), when compared to SAL-treated animals (WT: 71.6 ± 4.4%, hCAST: 67.2 ± 
4.2%, p<0.05) (Fig. 3.12), indicating that KA decreases neuronal survival. 
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Figure 3.11 - Mice treated with KA present higher number of new cells remaining 
in the DG after 8 weeks. WT and hCAST mice were treated with either SAL or KA and 
sacrificed 8 weeks after EdU administration. Representative images from hippocampal 
brain sections of SAL (A) and KA-treated (B) WT mice and SAL (C) and KA-treated (D) 
hCAST mice, showing EdU-positive cells in white. Scale bar: 200 µm. EdU-positive 
cells were counted in the SGZ, GZ and hilus of 5 mid hippocampal sections for each 
animal (E). Means ± SEM of 8 independent experiments were analyzed by a two-way 
ANOVA (Bonferroni’s post-test), *p<0.05, **p<0.01 and ***p<0.001, significantly 
different from SAL.  
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Figure 3.12 - Neuronal differentiation is impaired with KA treatment. WT and 
hCAST mice were treated with either SAL or KA and sacrificed 8 weeks after EdU 
administration, to assess neuronal differentiation. Representative images from 
hippocampal brain sections of EdU-positive/NeuN-positive (A) and EdU-positive/NeuN-
negative (B) cells in the DG, showing cells labeled for EdU in green and cells labeled 
for NeuN in red. Scale bar: 5 µm. The percentage of cells labeled for both EdU and 
NeuN in the DG (E) was determined in a total of up to 50 EdU-positive cells. Means ± 
SEM of 8 independent experiments were analyzed by a two-way ANOVA (Bonferroni’s 
post-test), *p<0.05, significantly different from SAL.  
 
3.3.2.3. Short-term impairment in object recognition memory after KA treatment 
is not present in mice overexpressing CAST 
 
Furthermore, to evaluate whether CAST overexpression would allow for a better and/or 
faster recovery after brain injury, we performed several cognitive behavioral tests on 
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WT and hCAST mice, on the 3rd (short-term) or 8th (long-term) week after treatment 
with either KA or SAL. We first tested the animals for object recognition memory, and 
took the opportunity, during habituation to the apparatus, to compare the overall 
locomotor activity and anxiety behavior of these mice. We observed that KA-treated 
mice presented similar levels of locomotor activity, as assessed by the number of line 
crossings and rearing behavior, when compared to SAL-treated animals in both short-
term recovery (line crossings, WT: 122.4 ± 17.4, hCAST: 110.0 ± 11.5; rearing, WT: 
30.0 ± 4.8, hCAST: 14.2 ± 3.4, p>0.05) (Fig. 3.13A) and long-term recovery (line 
crossings, WT: 126.7 ± 10.1, hCAST: 128.0 ± 9.1; rearing, WT: 26.4 ± 4.3, hCAST: 
25.1 ± 1.7, p>0.05) (Fig. 3.13B). 
 
 
Figure 3.13 - Locomotor activity is similar between SAL and KA treatments, for 
both WT and hCAST mice and recovery periods. WT and hCAST mice behavior 
was tested on the 3rd (short-term) or 8th (long-term) week after treatment with either 
SAL or KA. Locomotor activity was assessed in both short-term (A) and long-term (B) 
groups, by counting the number of line crossings and rearing episodes, during the open 
field test. Means ± SEM of 4-5 independent experiments (for short-term recovery) or 
12-16 independent experiments (for long-term recovery) were analyzed by a two-way 
ANOVA, p>0.05 between treatments.  
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Moreover, the anxiety behavior, measured by the number of central entries and time in 
the center, was also maintained after KA-treatment, in comparison with SAL, in both 
short-term recovery (central entries, WT: 14.8 ± 3.5, hCAST: 14.6 ± 2.3; time in center, 
WT: 19.1 ± 5.4 s, hCAST: 20.9 ± 5.8 s, p>0.05) (Fig. 3.14A) and long-term recovery 
(central entries, WT: 15.5 ± 1.6, hCAST: 14.5 ± 1.4; time in center, WT: 17.3 ± 2.9 s, 
hCAST: 16.2 ± 1.5 s, p>0.05) (Fig. 3.14B). 
 
 
Figure 3.14 - Anxiety behavior is similar between SAL and KA treatments, for 
both WT and hCAST mice and recovery periods. WT and hCAST mice behavior 
was tested on the 3rd (short-term) or 8th (long-term) week after treatment with either 
SAL or KA. Anxiety behavior was assessed in both short-term (A) and long-term (B) 
groups, by counting the number of entries into the central area and the time spent in 
the center, during the open field test. Means ± SEM of 4-5 independent experiments 
(for short-term recovery) or 12-16 independent experiments (for long-term recovery) 
were analyzed by a two-way ANOVA, p>0.05 between treatments. 
 
Regarding the object recognition test, we observed that, for both time periods, WT mice 
treated with SAL spent more time exploring the novel object (short-term recovery: 58.3 
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± 3.7%, long-term recovery: 62.9 ± 3.3%) than the familiar object, that they had already 
explored previously (short-term recovery: 41.7 ± 3.7%, p<0.05, long-term recovery: 
37.1 ± 3.3%, p<0.001). However, after KA treatment, only WT mice from the long-term 
recovery group were able to distinguish the novel object (58.9 ± 4.5%), from the 
familiar object (41.1 ± 4.5%, p<0.01) (Fig. 3.15, left panels), indicating impairment in 
recognition memory in the short-term group. On the other hand, all mice 
overexpressing CAST maintained the recognition memory for the novel object, in both 
short-term recovery (SAL, novel object: 61.5 ± 5.0%, familiar object: 38.5 ± 5.0%, 
p<0.01; KA, novel object: 61.1 ± 1.3%, familiar object: 34.9 ± 1.3%, p<0.001) and long-
term recovery (SAL, novel object: 62.9 ± 3.8%, familiar object: 37.1 ± 3.8%, p<0.001; 
KA, novel object: 59.7 ± 3.6%, familiar object: 40.3 ± 3.6%, p<0.001) (Fig. 3.15, right 
panels). 
 
 
Figure 3.15 - KA-treated WT mice present short-term impairment in recognition 
memory, but not hCAST mice. WT and hCAST mice behavior was tested on the 3rd 
(short-term) or 8th week (long-term) after treatment with either SAL or KA. Recognition 
memory was assessed in both short-term (A) and long-term (B) groups, by measuring 
the percentage of exploration time during the presentation of a novel object, in the 
object recognition test. Means ± SEM of 3-5 independent experiments (for short-term 
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recovery) or 12-15 independent experiments (for long-term recovery) were analyzed by 
a two-way ANOVA (Bonferroni’s post-test), *p<0.05, **p<0.01 and ***p<0.001, 
significantly different from familiar object. 
 
3.3.2.4. Long-term impairment in spatial memory for an exact location during the 
water maze test after KA treatment is not present in mice overexpressing CAST  
 
In order to study spatial learning and memory, the Morris water maze test was 
performed. During trials, we observed that KA-treated mice overexpressing CAST in 
the short-term recovery group learned more slowly the platform location, since the 
escape latency time on Day 2 (42.6 ± 10.2 s) was higher than in SAL (15.5 ± 3.6 s, 
p<0.05). However, on the beginning and by the end of the trials, escape latency was 
similar to SAL (Day 1: 39.4 ± 4.1 s, Day 3: 14.2 ± 4.7 s, p>0.05) (Fig. 3.16A). KA-
treated WT mice from this group learned the platform location similarly to SAL (Day 1: 
49.3 ± 7.3 s, Day 2: 36.3 ± 10.0 s, Day 3: 24.2 ± 10.9 s, p>0.05) on all days, as well as 
all KA-treated mice in the long-term recovery group (Day 1, WT: 38.4 ± 2.7 s, hCAST: 
47.9 ± 2.7 s; Day 2, WT: 26.4 ± 3.9 s, hCAST: 30.9 ± 5.3 s; Day 3, WT: 17.4 ± 4.9 s, 
hCAST: 20.7 ± 2.1 s, p>0.05) (Fig. 3.16). All mice showed improved spatial learning 
over the course of trials. 
After learning the platform location, the platform was removed and the spatial memory 
evaluated by calculating the percentage of time spent in the target quadrant (where the 
platform previously was) and by counting the number of crossings through the exact 
previous platform location. Time spent in the target quadrant was maintained with KA 
treatment in both time periods, by comparison with SAL (short-term recovery, WT: 60.4 
± 3.7%, hCAST: 49.0 ± 5.7%, p>0.05; long-term recovery, WT: 56.4 ± 4.1%, hCAST: 
49.0 ± 4.3%, p>0.05) (Fig. 3.17, left panels), indicating that all animals remembered the 
relative position of the platform. The number of platform crossings, in turn, also seemed 
to be maintained with KA treatment in the short-term recovery period when comparing 
to SAL (WT: 4.3 ± 1.6, hCAST: 3.8 ± 0.9, p>0.05) (Fig. 3.17A, right panel). However, in 
the long-term recovery period, the number of platform crossings is impaired in KA-
treated WT mice (2.4 ± 0.4) by comparison with SAL treatment (4.5 ± 0.7, p<0.05), 
indicating increased difficulty in remembering the exact platform location, which is not 
observed in mice onverexpressing CAST (SAL: 3.0 ± 0.6, p>0.05) (Fig. 3.17B, right 
panel). 
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Figure 3.16 - Escape latency during spatial learning improves slower with 
training in KA-treated mice overexpressing CAST from the short-term recovery 
group. WT and hCAST mice behavior was tested on the 3rd (short-term) or 8th (long-
term) week after treatment with either SAL or KA. Spatial learning was assessed in 
both short-term (A) and long-term (B) groups, by measuring the escape latency on the 
first 3 days of water maze (4 trials per day, latency of 60 s if the platform was not 
reached). Means ± SEM of 4-5 independent experiments (for short-term recovery) or 
11-16 independent experiments (for long-term recovery) were analyzed by a two-way 
ANOVA (Bonferroni’s post-test), *p<0.01, significantly different from hCAST SAL.  
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Figure 3.17 - Spatial memory for the exact platform location is impaired in KA-
treated WT mice from the long-term recovery group. WT and hCAST mice behavior 
was tested on the 3rd (short-term) or 8th (long-term) week after treatment with either 
SAL or KA. Spatial memory was assessed in both short-term (A) and long-term (B) 
groups, by measuring the percentage of time spent on the target quadrant and the 
number of crossings in the exact location the platform was during trials, on the last day 
of water maze. Means ± SEM of 4-5 independent experiments (for short-term recovery) 
or 11-16 independent experiments (for long-term recovery) were analyzed by a two-
way ANOVA (Bonferroni’s post-test), *p<0.05, significantly different from SAL. Example 
of an occupancy track plot, showing the route chosen by the animal in light blue (C). 
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3.3.2.5. Associative fear memory is preserved after KA treatment 
 
Lastly, associative learning and memory was evaluated, by performing the fear 
conditioning test. By the end of the trials, on the first day, all mice successfully learned 
to associate the cue tone with a footshock, by spending nearly half the time of the last 
hearing of the tone freezing, both in the short-term recovery (WT SAL: 42.7 ± 5.4%, 
hCAST SAL: 51.5 ± 5.3%, p>0.05) and in the long-term recovery (WT SAL: 48.9 ± 
6.8%, hCAST SAL: 47.1 ± 4.5%, p>0.05) (Fig. 3.18). 
 
 
 
Figure 3.18 - Associative learning was achieved similarly in all groups. WT and 
hCAST mice behavior was tested on the 3rd (short-term) or 8th (long-term) week after 
treatment with either SAL or KA. Associative learning was assessed in both short-term 
(A) and long-term (B) groups, by measuring the percentage of freezing time during fear 
conditioning trials, with the delivery of a footshock by the end of each cue tone. Means 
± SEM of 4-5 independent experiments (for short-term recovery) or 12-16 independent 
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experiments (for long-term recovery) were analyzed by a two-way ANOVA, p>0.05 
between treatments. Acqui. (acquisition). 
 
When tested for associative memory to context (context A), all KA-treated mice 
seemed to recognize the context similarly to SAL, both in the short-term recovery (WT: 
48.9 ± 6.8%, hCAST: 64.2 ± 10.8%, p>0.05) and in the long-term recovery (WT: 51.5 ± 
6.0%, hCAST: 69.4 ± 2.6%, p>0.05) (Fig. 3.19, upper panels). When in the context 
meant for the cued test (context B), hCAST mice from the short-term recovery group 
treated with KA spent significantly more time freezing than with SAL treatment (SAL: 
37.4 ± 7.2%, KA: 63.4 ± 9.8%, p<0.05), which was not observed in KA-treated WT 
mice, when compared to SAL (23.1 ± 4.5%, p>0.05) (Fig. 3.19A, lower left panel). In 
the long-term recovery group, the percentage of freezing time was more similar to SAL 
in both WT and hCAST mice (WT: 25.4 ± 4.4%, hCAST: 33.8 ± 4.4%, p>0.05) (Fig. 
3.19B, lower left panel). Moreover, all KA-treated mice seemed to maintain the 
associative memory to the cued stimulus by comparison with SAL, both in the short-
term recovery (WT: 56.7 ± 3.9%, hCAST: 75.5 ± 5.2%, p>0.05) and in the long-term 
recovery (WT: 69.1 ± 6.5%, hCAST: 75.1 ± 3.2%, p>0.05) (Fig. 3.19, lower right 
panels). 
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Figure 3.19 - KA treatment enhances associative memory to context B in hCAST 
mice from the short-term recovery period. WT and hCAST mice behavior was 
tested on the 3rd (short-term) or 8th (long-term) week after treatment with either SAL or 
KA. Associative memory to the context and cue tone were assessed in both short-term 
(A) and long-term (B) groups, by measuring the percentage of freezing time during the 
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fear conditioning context test (context A) and cued test, in a new context (context B). 
Means ± SEM of 3-5 independent experiments (for short-term recovery) or 9-16 
independent experiments (for long-term recovery) were analyzed by a two-way ANOVA 
(Bonferroni’s post-test), *p<0.05, significantly different from SAL. 
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3.5. Discussion 
 
The realization that the adult mammalian brain is not an immutable organ and that new 
neurons are actually able to form and thrive in the neuronal circuitry has opened new 
doors for the putative treatment of neurodegenerative disorders and brains lesions. 
This is due to fact that NSCs not only give origin to new neurons in the healthy brain, 
but are also known to increase the formation of new cells after a lesion, travelling as 
neuroblasts into regions where neurons were lost as a consequence of brain damage, 
in what seems like an endogenous attempt to replace those lost neurons. However, 
this process is not very efficient, as most of the new cells die, fail to integrate the 
networks, or do it erroneously (Kaneko & Sawamoto 2009, Ma et al. 2009). While cell 
transplantation into the sites of injury, for example, also seems promising, increasing 
endogenous neurogenesis would offer a less invasive approach for the treatment of 
brain damage. Our group has been interested in the study of the effects of calpains in 
this process, since they are proteases involved in neurodegeneration and their 
inhibition has been shown to be neuroprotective in several diseases (Saez et al. 2006). 
Furthermore, calpains have also been associated with cell proliferation, migration and 
differentiation in other systems (Kashiwagi et al. 2010, Lokuta et al. 2003, Paulhe et al. 
2001, Qiu et al. 2006, Raimbourg et al. 2013, Yajima & Kawashima 2002). One of the 
approaches we can use to study calpains is by modulating their selective endogenous 
inhibitor, CAST. We had previously seen that the absence of CAST impairs NSC 
proliferation in one of the neurogenic niches of the adult brain, the DG of the mouse 
hippocampus, and also hinders neuroblast migration, both in the DG and in the RMS, 
whose cells originate from another neurogenic niche, the SVZ. Moreover, calpain 
inhibition was shown to increase cell migration in explants from the SVZ (Machado et 
al. 2015). Work by Santos et al. has shown that calpain inhibition decreased cell 
proliferation in a NSC line, but also that it increased neuronal differentiation (Santos et 
al. 2012). However, this NSC line was originated from fetal brain, thus the mechanisms 
involved in these processes may be different from the ones occurring in the post-natal 
brain. Nonetheless, taken together, these evidences point to an involvement of 
calpains in the regulation of neurogenesis, so we were interested in investigating it 
further. SVZ-derived cells from the post-natal brain allow for the maintenance of 
numerous NSCs in culture, and provide for a model suitable for the analysis of 
neurogenesis in vitro, while analyzing SVZ neurogenesis in vivo may be more 
complicated. On the contrary, the low amount of NSCs in the DG make the analysis 
easier in brain sections, but these cells are difficult to isolate and maintain in culture. 
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The hippocampus is also a main target in several neurological disorders that affect 
mankind, making for a more attractive target for human disease modeling in vivo, 
rather than the SVZ. For that reason, we used SVZ-derived NSCs for the studies in 
vitro, and analyzed hippocampal neurogenesis in the mouse brain for the rest of the 
work. 
To complement the previous results seen with Cast KO mice, in which we observed an 
impairment of the early stages of hippocampal neurogenesis (Machado et al. 2015), we 
wanted to investigate whether calpain inhibition would reverse the impairment on NSC 
proliferation and neuroblast migration in these CAST-depleted mice. Since we were 
testing the pharmacological calpain inhibitor, calpeptin, in vitro, we first checked if the 
impairment in cell proliferation was maintained in cultured NSCs lacking CAST. In fact, 
as expected, we saw a progressive decrease in cell proliferation with the decrease of 
CAST levels, i.e., NSC proliferation in Cast Ht was impaired when compared to WT 
and, in turn, it was impaired in Cast KO, not only by comparison with WT, but also with 
Cast Ht. We then proceeded to treating WT and Cast KO cells with calpeptin, and 
verified that the impairment in NSC proliferation in mice lacking CAST was rescued by 
calpain inhibition. Concerning calpain activity in Cast KO mice, we also verified that 
cells from mice lacking CAST presented higher calpain activity in the presence of a 
calcium ionophore, by observing an increase of calpain-specific αII-spectrin breakdown 
products. We can therefore assume that the impairment in NSC proliferation observed 
is associated with increased activation of calpains, usually prevented by CAST, further 
involving them in this process. Moreover, calpain inhibition was also able to increase 
the proliferation of WT NSCs. Together with the previous observation of the 
enhancement of cell migration by calpeptin in SVZ explants, this indicates calpain 
inhibition as a possibility for increasing endogenous neurogenesis. 
Regarding cell migration when CAST is absent, however, the results obtained were not 
in accordance with our previous observations in vivo, since it was maintained in all of 
the approaches used. We measured radial migration and migration speed of cells 
leaving plated neurospheres, and also the area migrated by dissociated NSCs. Since 
mice lacking CAST show impairment in cell migration in vivo, both in the DG and the 
RMS, and since cells from the RMS are also derived from the SVZ, it seems unlikely 
that the fact that we did not observe these differences in vitro was due to the type of 
cells used. Lack of sensitivity of the approaches used to distinguish these variations 
could also be a possibility, but taking into account that we tried three different methods, 
and that one of them involved live tracking of migrating cells, this also does not seem to 
be the case. The most plausible hypothesis is the fact that one of the biggest problems 
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presented by in vitro studies is the difficulty to replicate the exact conditions of the 
environment that the cells encounter in vivo. This means that, for cell migration, 
something else in the environment might be helping calpains interfere with the process. 
Although we were not able to verify the involvement of calpains on cell migration in 
vitro, their clear involvement in NSC proliferation and the enhancement of cell 
proliferation and migration by calpain inhibition led us to investigate the effects of 
calpain inhibition after neuronal damage. For that purpose, we used mice 
overexpressing CAST and the KA model of seizure-induced hippocampal lesion. 
KA is a strong agonist of non-NMDA ionotropic glutamate receptors that induces 
excitotoxicity and consequent cell death, by activating ionotropic receptors highly 
abundant in the hippocampus (Carta et al. 2014, Wang et al. 2005). The KA model of 
brain lesion is thus often used for research involving hippocampal damage, especially 
in studies of temporal lobe epilepsy, since it mimics other features of this disease 
(Levesque & Avoli 2013). It is also a model recurrently used by our group for the 
investigation of hippocampal injury and its consequences (Araujo et al. 2008, Carreira 
et al. 2010, Carreira et al. 2015). Like with other types of brain damage, an 
enhancement of endogenous neurogenesis has also been reported after seizures. 
Independently of the model chosen to induce seizures in rodents, NSC proliferation is 
specially shown to be largely increased in the DG after just a few days (Gray & 
Sundstrom 1998, Huttmann et al. 2003, Jessberger et al. 2007a, Mohapel et al. 2004, 
Nakagawa et al. 2000, Parent et al. 1997, Sierra et al. 2015). Interestingly, evidence of 
increased cell proliferation has also been observed in the hippocampus of patients with 
temporal lobe epilepsy (Blumcke et al. 2001, Crespel et al. 2005). In the model used by 
our group, the peak of cell proliferation in the DG was shown to occur on day 5 after 
seizure induction, with a significant increase in neuroblast migration after 14 days 
(Carreira et al. 2015), results that we were able to replicate in the present work. This 
heavy enhancement of early neurogenesis indicates that the microenvironment in the 
hippocampus not long after seizures is extremely pro-neurogenic, which makes it 
difficult for changes due to altered levels of calpain activity to be observed. 
Nonetheless, since we have shown that increased calpain activity can impair NSC 
proliferation and migration of neuroblasts, it is important to exclude whether, in this 
case, calpain inhibition, by overexpression of CAST, increases cell proliferation and 
migration to alarming levels. An even more extreme rise in cell proliferation could 
originate unwanted cellular masses of undifferentiated cells, and more migrating cells 
could also mean more cells migrating into ectopic regions, interfering with the normal 
neuronal networks (Parent et al. 2006). Regarding cell proliferation, the enhancement 
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observed after KA treatment was similar in WT mice and in mice overexpressing 
CAST. Curiously, however, while the increase in neuroblast migration in KA-treated WT 
mice was around 4-fold, it dropped to 3-fold with the overexpression of CAST. Brain 
damage is closely associated with an increase in calpain activity, and it is known that 
calpain inhibition can be neuroprotective (Saez et al. 2006). This means that the fact 
that CAST was already overexpressed when seizures were induced may have 
attenuated the damage. Less damage could therefore also mean a less dramatic 
increase in neurogenesis, which in the long term could be favorable, proven that more 
cells would integrate correctly in the existing networks. Cell proliferation in the DG was 
shown by another group to substantially rise even after less severe seizures, with no 
further increase with seizure severity, indicating a threshold event (Mohapel et al. 
2004), which might explain why we observed a similar increase in cell proliferation 
even with the neuroprotective effect CAST overexpression might have provided during 
seizures. 
This increase in neurogenesis after lesion, however, is only efficient if the new cells 
ultimately differentiate, survive and integrate the neuronal circuitry correctly. After 
seizures, this is usually not the case. Despite the enhancement in the early stages of 
neurogenesis, most of the new cells end up differentiating into astrocytes, with 
relatively less neurons surviving 1-2 months after seizures (Carreira et al. 2015, 
Hattiangady & Shetty 2010, Sierra et al. 2015). Moreover, several newly formed 
neurons resembling granule cells are found ectopically in the hilus, and have also been 
reported to occur in patients with temporal lobe epilepsy (Parent et al. 2006, Parent et 
al. 1997). These ectopic granule-like hilar cells are hyperexcitable, contributing to a 
disruption of the existing neuronal networks and possibly aggravating the outcome of 
the disease (Dashtipour et al. 2001, Cameron et al. 2011). By overexpressing CAST, 
we were hoping to attenuate the survival impairment of new neurons in the DG after 
severe seizures and possibly reduce the presence of ectopic hilar cells, thus improving 
the efficiency of post-injury neurogenesis. Our findings with WT mice are consistent 
with what has been reported. After a 2-month period, there were significantly more new 
cells found in the hilus of mice treated with KA, as well as an increase in the number of 
new cells present in the SGZ and GZ of the DG. Since the percentage of new neurons 
was decreased in these mice, the overall increase in the number of new cells might be 
justifiable by the increased differentiation into astrocytes that occurs after seizures. The 
results obtained with mice overexpressing CAST were very similar, indicating that 
suppression of calpain activity is not enough to compensate for the impairment of 
neuronal differentiation in the DG. Although calpain inhibition was shown to increase 
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neuronal differentiation in vitro, in a cell line from fetal NSCs (Santos et al. 2012), we 
cannot exclude that in the developed brain calpains may not be involved in the 
process, or that other mechanisms may compensate for the decrease in calpain activity 
under a certain threshold, or even help in maintaining levels of calpain activity too 
elevated, especially in a pathologic environment. The inflammatory environment, e.g., 
may have some detrimental effects. Nitric oxide from inflammatory origin, for example, 
has been implicated in the neuronal impairment observed after seizures, in a different 
study performed by our group (Carreira et al. 2015). This multifactorial feature of brain 
pathology must thus be taken into account when developing new strategies for brain 
repair. 
Nonetheless, even though the percentage of neurons formed after seizures is not 
ameliorated by CAST overexpression, the ones that thrive may still be more functional 
and better integrated in the hippocampal neuronal networks. Since the hippocampus is 
the main structure involved in learning and memory, it is not surprising that treatment 
with KA in rodents can induce cognitive impairment (Stubley-Weatherly et al. 1996), 
which has also been reported in patients with temporal lobe epilepsy (Hattiangady & 
Shetty 2008). With this in mind, we were especially interested in verifying whether mice 
overexpressing CAST would show differences in cognitive recovery on the 3rd (short-
term) or 8th week (long-term) after KA treatment. In the short-term group, neurons born 
a few days after the brain insult are still immature and just starting to project their axons 
and dendrites and integrating the neuronal networks, while in the long-term group 
those neurons are already fully mature and integrated (Deng et al. 2010). 
Electrophysiology studies may also be performed to directly assess the functional 
behavior of the new neurons, but this was not addressed in our work. Although we 
were more interested in investigating the mice cognitive behavior, it is important to 
exclude the effects of general locomotor behavior and anxiety in these studies, 
especially since the hippocampus has also been related to anxiety (Barkus et al. 2010). 
Differences in locomotor activity and anxiety in these mice could lead to differences not 
related to cognition in the performance of the other tests, possibly giving rise to 
incorrect interpretation of the results. Due to its simplicity, the open field test is the most 
used for a general assessment of locomotor activity and anxiety behavior in rodents 
(Gould et al. 2009). Since it could be performed in the same apparatus, the habituation 
step of the object recognition test was therefore availed for that purpose. Overall, we 
did not find significant differences in locomotor activity or anxiety with KA treatment, 
suggesting that the brain areas related to these behaviors were relatively preserved 
after lesion. Therefore, any differences observed in the other tests should be related to 
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cognition per se. We then tested the mice for three different types of cognitive 
behavior: recognition memory (object recognition), spatial learning and memory (water 
maze) and associative learning and memory (fear conditioning). The object recognition 
test makes use of the natural exploratory behavior of rodents. In the presence of a 
familiar and a novel object, rats and mice will normally spend relatively more time 
exploring the novel one, in a process shown by several studies to implicate the 
hippocampus (Cohen & Stackman 2015). It was thus not a surprise that KA treatment 
impaired recognition of the previously explored object in WT mice from the short-term 
recovery group. In the long-term group, however, this impairment seemed to be 
overcome, suggesting that the newly formed cells ultimately succeeded in restoring the 
networks necessary for object recognition. Interestingly, CAST overexpression 
prevented impairment after KA treatment even in the short-term group. Having in mind 
that in this group the newly formed neurons are still immature, it is unlikely that they 
were already able to restore lost connections. This might thus mean that the regions 
involved in recognition memory were less affected when CAST was overexpressed, in 
accordance with the aforementioned neuroprotective effect afforded by calpain 
inhibition. 
Spatial memory, in turn, has long been known to require the hippocampus, being one 
of the most affected by hippocampal lesions (Best et al. 2001, Martin & Clark 2007). In 
a fundamental work by Richard Morris (Morris et al. 1982), e.g., rats with hippocampi 
removed took longer to learn to reach an escape platform hidden in a pool, but not a 
visible platform, and also had more difficulty in distinguishing the exact previous 
escape location when the platform was removed from the pool, indicating the 
importance of the hippocampal integrity in navigating through space using only distal 
environmental cues. In our study, we used this Morris water maze test to investigate 
whether impairment in spatial memory was also seen in our model and if CAST 
overexpression could be beneficial. In the short-term group, we observed that, even 
though KA-treated mice seemed to take a bit longer to learn to reach the escape 
platform, by the end of the trials they performed similarly to the SAL-treated controls. 
Moreover, all animals spent a high percentage of time in the target quadrant when 
platform was removed, and there seemed to be no differences in the number of 
crossings over the exact previous platform location. However, the low number of 
animals used in the short-term group seemed to affect this cognitive test the most, and 
the increased variability especially during trials and platform crossings makes it difficult 
to take reliable conclusions from this group. Nonetheless, when assessing the results 
from the long-term group, we could clearly see that all animals were able to learn to 
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reach the platform during trials, and also spent a high percentage of time in the target 
quadrant when platform was removed. The number of crossings over the exact 
previous platform location, however, was impaired in KA-treated WT mice in 
comparison with SAL, which is not seen in mice overexpressing CAST. Interestingly, 
certain neurons in the hippocampus, the place cells, have the peculiarity of firing only 
when the animal enters a specific position in space, and different place cells respond to 
different locations of the same environment, allowing the brain to create a spatial map 
of that particular environment (O'Keefe & Dostrovsky 1971). Additionally, a study on 
the pattern of place-cell activity during a water maze test in rats has shown that the 
percentage of place cells firing maximally was more than doubled near the platform 
when compared to other locations in the pool (Hollup et al. 2001), indicating a great 
contribution of these cells to the correct mental positioning of the platform in this 
particular task. Our results may suggest a loss of place cells or correct place-cell 
activity in WT mice treated with KA, since they seemed to have only a general idea of 
the platform whereabouts, but failed to determine exactly where it was, as compared to 
SAL-treated mice. This notion is further corroborated by a study showing that seizure-
induced hippocampal lesion can indeed affect the activity of place cells several weeks 
later, making them less precise and less stable (Liu et al. 2003). The existing place 
cells in mice overexpressing CAST seem therefore to be less affected by KA treatment, 
suggesting that calpain inhibition may also limit the seizure-induced damage of these 
cells. 
Finally, the fear conditioning test was the last to be performed, since it was the most 
stressful for the animals, due to the footshock they received during learning. This test is 
based on the association of an aversive stimulus with a tone and with the context 
where it occurred, which is measured by the time the animal spends freezing, i.e., 
when the only observed movement is from breathing, a known indicative of fear in 
rodents (Blanchard & Blanchard 1969, Wehner & Radcliffe 2004). As with the other 
performed cognitive tests, the fear conditioning test also has the involvement of the 
hippocampus, but only in relation to context, being the response to the cued stimulus 
dependent on the integrity of the amygdala (Phillips & LeDoux 1992), reiterating the 
relationship of the hippocampus with spatial features. For that reason, during learning, 
we were expecting all mice to associate the cued tone with the aversive stimulus, with 
progressively more time spent freezing with further tone presentations. Indeed, by the 
last time the tone was played, all animals spent around half of the time freezing, in 
contrast with virtually no freezing that was observed when they were first placed in the 
chamber. On the following day, the animals were placed in the exact same context, 
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without presentation of tone or footshock, and SAL-treated animals presented 
associative memory to this context, by presenting freezing behavior for most of the time 
spent inside the chamber, as expected. However, KA-treatment failed to impair the 
time spent freezing, which may be linked with the relative resistance of the used strain 
to KA-induced cell death (McKhann et al. 2003). Even though differences in associative 
memory to the context where the mice received the aversive stimulus might have been 
too subtle for detection, freezing to the modified context was significantly increased in 
KA-treated mice overexpressing CAST from the short-term recovery group. Unlike all 
other mice, that seemed to understand the context was different, these mice seemed to 
assimilate that they were in a similar situation as before and missed the change of 
context in the experiment cage, suggesting hippocampal function impairment. One 
interesting feature of the aforementioned place cells is that they can be involved in the 
mechanisms of pattern separation, the ability to discriminate between very similar 
memories, and pattern completion, the ability to recall a previous memory in full based 
only on some of the components that composed that memory (Sahay et al. 2011). If 
these mechanisms are not balanced, there is an alteration in the perception of the 
environment. For instance, if pattern completion is relatively enhanced, there is 
generalization of the current environment, which means that several contexts may be 
linked together, even if they present reduced similarities (Sahay et al. 2011). This 
imbalance may thus be what caused KA-treated hCAST mice from the short-term 
group to present higher freezing in the modified context, since the small similarities 
between both contexts seemed to be enough for them to recall the aversive stimulus. A 
possible explanation for this may relate to the findings that young granule cells 
(immature neurons) seem to be involved with pattern separation and older granule cells 
with pattern completion (Nakashiba et al. 2012). Given the neuroprotection provided by 
calpain inhibition, less neurons are expected to be lost after KA-treatment in mice 
overexpressing CAST. Assuming that old neurons are more resistant, relatively more 
younger ones would die (Spalding et al. 2013). We show previously in this chapter that 
KA enhances the early stages of neurogenesis, so an increased number of younger 
granule cells is expected to exist in the hippocampus of mice from the short-term 
group. At first, the new cells do not appear to be enough, or functional enough, to 
compensate for the relative higher number of older cells, though later on they seem to 
regain balance, since the differential behavioral response to the new context of hCAST 
mice treated with KA from the short-term recovery group is lost in the long-term group. 
On the other hand, assuming that without neuroprotection younger and older neurons 
are lost more or less equally in KA-treated WT mice, and since the balance between 
younger and older granule cells seems to be maintained, by observation of memory 
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association to the new context, we suggest that the new young neurons may not be 
fully functional. Electrophysiology studies would help to evaluate if this is in fact the 
case. Lastly, like with learning, we were expecting, and observed, associative memory 
to the cue tone to be maintained in all animals, since the hippocampus does not seem 
to be involved in this process.  
These results seem to corroborate the neuroprotective effect of calpain inhibition, 
though the fact that CAST was already overexpressed prior to lesion may have masked 
potential benefits of calpain inhibition on post-injury neurogenesis, since the injury on 
CAST mice may have been smaller. Moreover, the fact that the absence of CAST and, 
consequently, increased calpain activity, can impair early hippocampal neurogenesis, 
does not necessarily mean that reduced or lack of calpain activity can enhance it, 
which is addressed in the next chapter of this thesis. 
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4.1. Summary 
 
In the brain, calpains have mostly been related with neuronal damage, but the 
information regarding how they may affect neurogenesis is limited. Absence of the 
endogenous inhibitor of calpains, calpastatin, has been shown to impair NSC 
proliferation and neuroblast migration in the hippocampus of adult mice. In this work, 
we wanted to evaluate whether decreased calpain activity could enhance these early 
stages of hippocampal neurogenesis. For that purpose, we used mice lacking one or 
both of the most abundant calpain isoforms, calpain 1 and calpain 2, and evaluated the 
effects on this process. We thus used mice lacking calpain 1, conditional neural 
knockout mice for calpain 2 and double-knockout mice for both calpain 1 and calpain 2, 
resulting from crossing the previous two animals, and evaluated neural stem cell 
proliferation and neurobast migration in the dentate gyrus of the hippocampus of adult 
mice. We observed that the lack of calpains did not alter early stages of hippocampal 
neurogenesis, which, taken together with our previous reports, suggest that calpains 
only seem to be involved in hippocampal neurogenesis when their activity is over a 
certain threshold, which is usually prevented by the inhibitory effect of calpastatin. 
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4.2. Introduction 
 
Neurogenesis is now currently accepted to occur in the adult mammalian brain, in the 
walls of the lateral ventricles, as well as in the hippocampus (Bond et al. 2015). Several 
factors can affect adult neurogenesis, including brain pathology. Interestingly, the brain 
seems to have an endogenous attempt to repair itself. Early stages of neurogenesis 
can be increased after lesion, though the efficiency of the process is limited by 
impaired cell migration or decreased survival of new neurons (Kaneko & Sawamoto 
2009, Ma et al. 2009). Changes in the environment after a pathological event may 
partially affect the efficiency of adult neurogenesis, and understanding how these 
changes affect the process could contribute to a better outcome for brain repair. 
One of the changes observed in a pathological environment is the increased activity of 
some proteases, including calpains (Neumar et al. 2001). Calpains are known to cleave 
a plethora of substrates and therefore act on several cellular processes, including cell 
proliferation and migration (Goll et al. 2003). Absence of the endogenous inhibitor of 
calpains, calpastatin (CAST), impairs early stages of hippocampal neurogenesis, 
involving increased calpain activity in the process (Machado et al. 2015).  
We therefore proposed to evaluate whether the lack of one or both of the most 
abundant calpain isoforms, calpain 1 and calpain 2, could increase early stages of 
hippocampal neurogenesis. We thus used mice lacking calpain 1 (Capn1 KO), 
conditional neural knockout mice for calpain 2 (Capn2 cKO) and double-knockout mice 
for both calpain 1 and calpain 2, resulting from crossing the previous two animals 
(Capn1&2 cDKO), and evaluated neural stem cell (NSC) proliferation and neuroblast 
migration in the dentate gyrus (DG) of the hippocampus of adult mice. Conditional 
knockout mice must be used for calpain 2, since conventional knockout mice for this 
protease are embryonically lethal (Dutt et al. 2006, Takano et al. 2011). 
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4.3. Results 
 
4.3.1. Calpain depletion maintains early neurogenesis in the adult hippocampus 
 
To study the effects of calpain depletion on early neurogenesis, the presence of Cre, 
Capn1 and loxp sites for Capn2 in the mice DNA were verified by genotyping (Fig. 
4.1A). Presence of CAPN2 was checked in hippocampal lysates (Fig. 4.1B) and, since 
we were not able to acquire a reliable antibody to verify CAPN1 expression by Western 
blot or immunohistochemistry, we trusted the validation work published on these 
animals (Azam et al. 2001, Takano et al. 2011). 
In order to evaluate NSC proliferation in the subgranular zone (SGZ) of the DG, mice 
were given 5-ethynyl-2’-deoxyuridine (EdU) on the day before sacrifice. We observed 
that depletion of calpains, as well as the presence of Cre, used as controls of Cre 
expression (Cre Ctrl), maintained NSC proliferation, by comparison with wild-type (WT, 
17.7 ± 1.9 cells/section, p>0.05), as assessed by the number of cells that incorporated 
EdU in the SGZ (Fig. 4.2). 
Furthermore, mice were also given 5-bromo-2’-deoxyuridine (BrdU) one week prior to 
sacrifice, and the evaluation of cell migration in the DG was performed by three 
different approaches: distribution of newborn cells, overall neuroblast migration and 
distance of migration of newborn cells into the granular zone (GZ). The distribution of 
newborn cells in the DG, as assessed by BrdU incorporation, seemed to be preserved 
in the DG of mice lacking calpains, as well as in the presence of Cre, when compared 
to WT mice (SGZ: 47.0 ± 3.5 cells/section, GZ: 7.9 ± 0.7 cells/section, p>0.05) (Fig. 
4.3). 
Overall neuroblast migration was assessed by doublecortin (DCX) labeling, and was 
also shown to be maintained when calpains are depleted, as well as in the presence of 
Cre, by comparison with WT (3.4 ± 0.2%, p>0.05) (Fig. 4.4). 
Similarly to what was seen with the other approaches used to study cell migration in 
the DG of mice lacking calpains, as well as in the presence of Cre, the distance of 
migration of newborn cells into the GZ was also maintained, when compared to WT 
(18.2 ± 1.3 µm, p>0.05) (Fig. 4.5). 
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Figure 4.1 - Genotyping profiles and detection of CAPN2. Genotyping profiles for 
Cre, Capn1 and Capn2 (A). Western blot analysis of hippocampal lysates to detect 
presence of CAPN2. GAPDH was used as a loading control (B). 
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Figure 4.2 - Absence of calpains maintains NSC proliferation in the DG. Mice were 
given EdU on the day before sacrifice, to assess cell proliferation. Representative 
images from hippocampal brain sections of WT (A), Capn1 KO (B), Capn2 cKO (C), 
Capn1&2 cDKO (D) and Cre Ctrl (E) mice, showing EdU-positive cells in white. Scale 
bar: 200 μm. EdU-positive cells were counted in the SGZ of 5 mid hippocampal 
sections for each animal (F). Means ± SEM of 6-9 independent experiments were 
analyzed by a one-way ANOVA, p>0.05.  
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Figure 4.3 - Lack of calpains preserves distribution of BrdU-positive cells in the 
DG. Mice were given BrdU one week before sacrifice, to assess cell migration. 
Representative images from hippocampal brain sections of WT (A), Capn1 KO (B), 
Capn2 cKO (C), Capn1&2 cDKO (D) and Cre Ctrl (E) mice, showing BrdU-positive cells 
in white. Scale bar: 200 μm. BrdU-positive cells were counted in the SGZ and GZ of 5 
mid hippocampal sections for each animal (F). Means ± SEM of 5-7 independent 
experiments were analyzed by a one-way ANOVA, p>0.05. 
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Figure 4.4 - Overall neuroblast migration in the DG is preserved when calpains 
are depleted. DCX immunoreactivity was used to assess cell migration. 
Representative images from hippocampal brain sections of WT (A), Capn1 KO (B), 
Capn2 cKO (C), Capn1&2 cDKO (D) and Cre Ctrl (E) mice, showing migrating 
neuroblasts, labeled for DCX, in white. Scale bar: 100 µm. Percentage of DCX-positive 
area was determined in the DG of 5 mid hippocampal sections for each animal (F). 
Means ± SEM of 6-9 independent experiments were analyzed by a one-way ANOVA, 
p>0.05. 
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Figure 4.5 - Calpain deficiency maintains the migration distance of newborn cells 
into the GZ of the DG. Mice were given BrdU one week before sacrifice, to assess cell 
migration. Representative images from hippocampal brain sections of WT (A), Capn1 
KO (B), Capn2 cKO (C), Capn1&2 cDKO (D) and Cre Ctrl (E) mice, showing BrdU-
positive cells in green and migrating neuroblasts, labeled for DCX, in red. Scale bar: 20 
µm. Distance migrated from the SGZ into the GZ by BrdU-positive/DCX-positive cells 
were measured in a total of at least 33 cells per group, from 5 images acquired for 
each animal (F). Means ± SEM of 5-7 independent experiments were analyzed by a 
one-way ANOVA, p>0.05. 
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4.4. Discussion 
 
Calpains are key players in the neuronal damage that occurs after a brain lesion, which 
makes it not surprising that inhibition of these proteases is shown to be neuroprotective 
in a variety of models of neurodegenerative diseases and other types of brain damage 
(Saez et al. 2006). On the other hand, brain damage has also been associated with an 
enhancement of endogenous neurogenesis, the process that culminates in the birth of 
new neurons. Following a lesion, NSCs present in neurogenic niches increase 
proliferation, and migrating neuroblasts are then re-routed into the affected regions, 
where new neurons differentiate, but very few end up successfully replacing the lost 
neurons (Kaneko & Sawamoto 2009, Ma et al. 2009). Since calpains can cleave a 
plethora of substrates, it is also not surprising that they can affect several cellular 
processes, including cell proliferation, migration and proliferation (Kashiwagi et al. 
2010, Lokuta et al. 2003, Paulhe et al. 2001, Qiu et al. 2006, Raimbourg et al. 2013, 
Yajima & Kawashima 2002), which are key stages in the process of neurogenesis. 
However, the involvement of calpains in these processes in the brain remains elusive, 
but could potentially shed new light into how endogenous neurogenesis can be 
modulated. We have previously seen in our group that increased calpain activity can 
indeed affect adult neurogenesis, since the lack of CAST, the endogenous calpain 
inhibitor, impaired both NSC proliferation and neuroblast migration in mice (Machado et 
al. 2015). Nevertheless, in the event of a brain lesion, successfully enhancing 
neurogenesis would be more relevant. Inhibition of calpains could thus potentially help 
with neuroregeneration, in addition to being neuroprotective. As seen in the previous 
chapter, however, overexpressing CAST seemed to more or less maintain the 
neurogenesis pattern observed after kainic acid (KA)-induced hippocampal lesion, but 
its influence on post-injury neurogenesis may have been masked by the 
neuroprotective effect of calpain inhibition. Thus, we could not clearly conclude whether 
calpain inhibition had the potential to enhance endogenous neurogenesis. Since CAST 
can be modulated by other factors in vivo, we decided to use knockout mice for one or 
both of the most abundant calpain isoforms in the brain, calpain 1 and calpain 2 (Ono & 
Sorimachi 2012), in order to evaluate the possible effects on early hippocampal 
neurogenesis. Mice lacking calpain 1 are viable (Azam et al. 2001), but mice lacking 
calpain 2 or the small regulatory subunit, associated with both isoforms, present 
embryonic lethality (Dutt et al. 2006, Takano et al. 2011). However, the establishment 
of conditional knockout mice for calpain 2 prevented the embryonic lethality (Takano et 
al. 2011) and conditional knockout mice in which calpain 2 is absent mostly in cells 
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from the central and peripheral nervous system interested us for the study on 
hippocampal neurogenesis. We therefore evaluated NSC proliferation and neuroblast 
migration in the hippocampus of conventional knockout mice for calpain 1 (CAPN1 
KO), conditional knockout mice for calpain 2 (CAPN2 cKO) and knockout mice for both 
calpains 1 and 2 (CAPN1&2 cDKO), in comparison with WT mice. Mice expressing 
both calpain 1 and calpain 2 normally, but that also expressed Cre recombinase in the 
same conditions as CAPN2 cKO and CAPN1&2 cDKO were used as controls (Cre Ctrl 
mice), to exclude any influence of Cre itself on the evaluated parameters. 
Considering that the absence of CAST impairs the early stages of hippocampal 
neurogenesis (Machado et al. 2015), we were expecting an enhancement of this 
process with the absence of calpains. For the assessment of NSC proliferation, the 
thymidine analogue EdU was administered to the mice, which were sacrificed on the 
following day. Cells that incorporated EdU would therefore be the ones in the 
proliferative stage. Contrary to what we were expecting, cell proliferation in the SGZ of 
the hippocampus was maintained in all animals. Nonetheless, calpains can also affect 
cell migration, and some of the studies on the subject have shown that reduced calpain 
activity can enhance the migration ability of certain cell types (Lokuta et al. 2003, 
Kuchay et al. 2012, Noma et al. 2009, Katsube et al. 2008, Raimbourg et al. 2013). In 
our study, we evaluated the effects of the lack of calpains on neuroblast migration in 
the mouse hippocampus, using three different approaches, as previously reported 
(Machado et al. 2015). Another thymidine analogue, BrdU, was administered to the 
mice one week prior to sacrifice, to give cells that incorporated BrdU time to migrate. 
The first approach used was BrdU distribution in the DG. NSCs from the DG proliferate 
in the SGZ and then migrate as neuroblasts into the GZ, where they later differentiate 
into new granule neurons (Aimone et al. 2014). If neuroblast migration is affected, 
differences in the migration of newborn cells into the GZ should be observed. However, 
distribution of BrdU cells seemed to be preserved in the DG of all mice. This was 
further corroborated by the other two approaches used, consisting in the evaluation of 
the overall area of migrating neuroblasts and distance of migration of newborn cells 
into the GZ, which also seemed to be preserved in all animals. Moreover, the observed 
results with CAPN2 cKO and CAPN1&2 cDKO mice were not influenced by the 
presence of Cre, since Cre Ctrl mice presented results similar to WT. The maintenance 
of NSC proliferation and neuroblast migration in mice lacking either calpain 1 or calpain 
2 could have been due to a possible mutual compensatory effect of these isoforms. 
However, mice lacking both calpains presented similar results, discarding that 
hypothesis. Since increased calpain activity impairs these early stages of neurogenesis 
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(Machado et al. 2015), another explanation can be that calpains only influence 
physiologic hippocampal neurogenesis when their activity rises over a certain 
threshold, and not when the activity is diminished. However, calpain inhibition is able to 
enhance cell proliferation and migration in vitro, in cells derived from the subventricular 
zone (Machado et al. 2015), which means that calpain inhibition may still hold promise 
in enhancing subventricular zone neurogenesis. 
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With the present work, we aimed at further investigating how modulation of calpain 
activity could affect the process of neurogenesis. Calpain inhibition is known to be 
neuroprotective and calpains also play a role in the processes of cell proliferation, 
migration and differentiation, which are key stages on the formation of new neurons. 
However, very little is known about the effects of calpains on neural stem cells (NSC) 
and the overall process of neurogenesis. Finding a way to modulate calpain activity in 
order to help improve the outcome of post-injury neurogenesis, the endogenous 
attempt to restore neurons lost as a consequence of brain damage, would highly 
benefit patients with neurodegenerative diseases or other types of brain insults. 
We have previously seen that increased calpain activity impaired, in vivo, NSC 
proliferation in one of the neurogenic niches of the adult brain, the dentate gyrus (DG) 
of the hippocampus, and also neuroblast migration in the DG and the rostral migratory 
stream, which originates from another highly neurogenic niche in the brain, the 
subventricular zone (SVZ). In this work, we show that increased calpain activity can 
also impair NSC proliferation in vitro, in cultures derived from the SVZ of post-natal 
mice, and that this impairment is rescued by calpain inhibition. Moreover, calpain 
inhibition was also able to increase wild-type (WT) NSC proliferation and, in previous 
results by our group, cell migration in explants from the SVZ. Calpain inhibition seemed 
thus a promising approach for the enhancement of neurogenesis after brain lesion. 
We also investigated the effects of calpain inhibition on post-injury neurogenesis. We 
used mice overexpressing calpastatin (CAST), the endogenous inhibitor of calpains, 
and the kainic acid model of seizure-induced hippocampal lesion, currently in use by 
our lab. We show that the high increase in NSC proliferation in the DG after lesion is 
maintained with CAST overexpression, probably due to a threshold event, in which a 
small lesion is able to trigger maximally the increase in NSC proliferation. However, 
even though neuroblast migration in the DG also increased considerably after lesion 
with CAST overexpression, this increase seemed to be more attenuated in these mice. 
We propose that, since calpain inhibition can be neuroprotective and CAST was 
already overexpressed in these animals before lesion, the extension of the damage 
was probably reduced, so the recruitment of fewer cells was needed to repair the 
damage. Following migration, we assessed cell differentiation in the DG, but 
suppression of calpain activity by overexpression of CAST did not seem to be enough 
to compensate for the increase of ectopic newborn cells and for the impairment in 
neuronal differentiation that occur after lesion. Though we cannot exclude the 
possibility that calpains might not be involved in neuronal differentiation in the adult 
brain, or at least in the hippocampus, we think that a better outcome may have been 
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prevented by the pathologic conditions in the environment. This pathologic environment 
must thus not be overlooked when developing new strategies for brain repair. 
Although CAST overexpression was not able to increase the percentage of new 
neurons in the DG after lesion, they could still be more functional and better integrated 
in the neuronal circuits. Since the hippocampus is highly involved in learning and 
memory, we decided to investigate whether the cognitive behavior could be improved 
in these mice. We chose two time-points to evaluate cognitive recovery: on the 3rd 
week after treatment, when the newborn neurons are still immature (short-term group) 
and on the 8th week after treatment, when the newborn neurons are already mature 
and integrated in the existing networks. We found that recognition memory was only 
impaired in WT mice from the short-term recovery group, and not with CAST 
overexpression. This is another indicator of neuroprotection by calpain inhibition, since 
newborn neurons are still not fully mature at this stage to have been able to reverse the 
damage. Moreover, regarding spatial memory, calpain inhibition also seemed to either 
prevent damage or to have successfully allowed for the correct replacement of place 
cells in the hippocampus, since mice overexpressing CAST from the long-term group 
did not present increased difficulty in remembering an exact spatial location, in contrast 
to lesioned WT mice. Lastly, associative memory to a modified context after fear 
conditioning to an aversive stimulus seemed to only be affected in the short-term 
group, with overexpression of CAST. These mice apparently understood better that 
they were in a similar situation as when they received a footshock, even though we 
tried to change the context as much as possible. This led us to propose that an 
imbalance in the proportion of immature and mature neurons, due to possible 
increased neuroprotection of more mature neurons, could have enhanced the process 
of pattern completion in these mice, inducing the association of both contexts by the 
few similarities between the two. All of the cognitive results therefore corroborate the 
neuroprotection granted by calpain inhibiton, though it would be important to 
confidently be able to determine whether reduced calpain activity could in fact 
positively affect neurogenesis. 
Having this in mind, for our last set of experiments, we decided to use mice lacking 
calpains, in order to assess whether absence of activity of one or both of the calpain 
isoforms most abundant in the brain would be able to enhance the early stages of 
hippocampal neurogenesis. However, neither NSC proliferation nor neuroblast 
migration seemed to be affected by impairment of calpain activity. Considering that 
increased calpain activity impairs these early stages of hippocampal neurogenesis, we 
propose that calpains only affect this process when their activity is over a certain 
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threshold, under which neurogenesis is not affected. Taken together, the results in this 
work clearly involve calpains in the early stages of neurogenesis.  
In conclusion, even though reduced calpain activity does not seem to be able to 
enhance hippocampal neurogenesis, it could potentially be able to prevent the 
impairment in the formation of new neurons after injury, given that the levels of calpain 
activity could be reduced under a certain threshold. Strategies to reduce the harmful 
effects of the pathologic environment, such as controling neuroinflammation, for 
example, could also help boost the outcome of calpain inhibition in the survival of new 
neurons. Moreover, these observations are in regard to hippocampal neurogenesis. 
Cells derived from the SVZ seem to hold more promise to present enhanced 
proliferation and migration with calpain inhibition, encouraging further research 
involving these cells and calpain activity in the field of brain damage. 
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